https://iowahealthcarereporter.com/article/913859717-leafwell-advances-medical-cannabis-as-clinically-validated-solution-for-cancer-related-symptoms-and-chronic-pain-supports-employer-sponsored-mental Iowa Healthcare Reporter en PressRelease 2026-05-20T15:17:15+00:00 Leafwell Advances Medical Cannabis as Clinically Validated Solution for Cancer-Related Symptoms and Chronic Pain, Supports Employer-Sponsored Mental Health Benefits https://ml.globenewswire.com/media/86423433-b118-4b2b-8f83-a8cc0d68098c/small/leafwell-logo-green-and-black-2021-png.png https://iowahealthcarereporter.com/article/913859700-mink-therapeutics-reports-new-data-on-agent-797-an-allo-inkt-cell-therapy-at-ats-2026-simultaneously-published-in-clinical-immunology-communications Iowa Healthcare Reporter en PressRelease 2026-05-20T15:07:14+00:00 MiNK Therapeutics Reports New Data on agenT-797, an allo-iNKT Cell Therapy at ATS 2026; Simultaneously Published in Clinical Immunology Communications https://ml.globenewswire.com/media/6aa8e960-515a-40d6-9894-39ca47f5c84e/small/mink-logo-loyal-blue-and-light-blue-png.png https://iowahealthcarereporter.com/article/913859093-ama-unveils-infographic-to-help-patients-safely-navigate-ai-in-healthcare Iowa Healthcare Reporter en PressRelease 2026-05-20T14:30:00+00:00 AMA Unveils Infographic to Help Patients Safely Navigate AI in Healthcare https://ml.globenewswire.com/media/YWI5ZWE1ZGItMGJhMC00ZmU3LWIwZjctYTdlNzVmNTIxMjJkLTEwOTg0MDUtMjAyNi0wNS0yMC1lbg==/tiny/American-Medical-Association.png https://iowahealthcarereporter.com/article/913858606-how-to-boost-testosterone-after-40-safe-testosterone-boosters-for-men-over-40-and-50-for-muscle-growth-energy-stamina-and-performance-in-2026 Iowa Healthcare Reporter en PressRelease 2026-05-20T14:19:09+00:00 How To Boost Testosterone After 40?| Safe Testosterone Boosters for Men Over 40 and 50 For Muscle Growth, Energy, Stamina and Performance in 2026 – Launched By Testoprime https://ml-eu.globenewswire.com/Resource/Download/329f05ae-17dd-42ae-88e0-9b7ff687ebcf/image2.png https://iowahealthcarereporter.com/article/913858813-ronald-mcdonald-house-new-england-launches-brand-revitalization-deepening-its-mission-to-keep-families-close Iowa Healthcare Reporter en PressRelease 2026-05-20T14:00:00+00:00 Ronald McDonald House New England Launches Brand Revitalization, Deepening its Mission to Keep Families Close https://pressranger.s3.us-west-1.amazonaws.com/3291515/rmh_newengland_logo_hrz_color_rgb_pos.png https://iowahealthcarereporter.com/article/913859084-regional-health-properties-reports-first-quarter-2026-results Iowa Healthcare Reporter en PressRelease 2026-05-20T13:41:00+00:00 Regional Health Properties Reports First Quarter 2026 Results https://ml.globenewswire.com/media/bfd51062-4a60-4cf0-9f2f-a4b109b52e4a/small/logo-jpg.jpg https://iowahealthcarereporter.com/article/913835677-tru-1-by-bluegenes-launches-to-advance-precision-health-through-smarter-genetic-insights Iowa Healthcare Reporter en PressRelease 2026-05-20T13:15:00+00:00 Tru-1 By BlueGenes Launches to Advance Precision Health Through Smarter Genetic Insights https://ml.globenewswire.com/media/ZWViMTQwZTctODE3YS00NGIwLTk0NzgtYjIyYzQzNzYwOWM3LTUwMDEzNTI2MC0yMDI2LTA1LTIwLWVu/tiny/BlueGenesLab.png https://iowahealthcarereporter.com/article/913834406-new-studies-show-adherence-to-monthly-injectable-buprenorphine-is-associated-with-relapse-reduction-and-lower-healthcare-utilization Iowa Healthcare Reporter en PressRelease 2026-05-20T13:00:00+00:00 New Studies Show Adherence to Monthly Injectable Buprenorphine is Associated with Relapse Reduction and Lower Healthcare Utilization https://ml-eu.globenewswire.com/media/42de3285-90ea-4020-a3ad-25f71026b41a/small/indivior-logo-jpg.jpg https://iowahealthcarereporter.com/article/913835062-biostem-technologies-announces-notice-of-allowance-for-four-u-s-design-patent-applications-covering-fenestrated-human-placental-allografts-and-one Iowa Healthcare Reporter en PressRelease 2026-05-20T13:00:00+00:00 BioStem Technologies Announces Notice of Allowance for Four U.S. Design Patent Applications Covering Fenestrated Human Placental Allografts and One European Patent https://ml.globenewswire.com/media/f4323fdf-217c-4eaf-94ad-897e8158965b/small/biostem-technologies-logo.png https://iowahealthcarereporter.com/article/913835675-aeroflow-urology-donates-to-national-diaper-bank-network-and-united-way-to-improve-national-health-equity Iowa Healthcare Reporter en PressRelease 2026-05-20T13:00:00+00:00 Aeroflow Urology Donates to National Diaper Bank Network and United Way to Improve National Health Equity https://ml.globenewswire.com/media/f0030ee9-d8c8-4321-a610-4bb1ed358418/small/aeroflow-health-png.png https://iowahealthcarereporter.com/article/913835697-jenavalve-appoints-tonya-porter-as-vice-president-of-regulatory-affairs Iowa Healthcare Reporter en PressRelease 2026-05-20T13:00:00+00:00 JenaValve Appoints Tonya Porter as Vice President of Regulatory Affairs https://ml.globenewswire.com/media/a1ab2446-a463-4b8f-bc18-26a5ca117176/small/jv-logo-h-rgb-l-1607-png.png https://iowahealthcarereporter.com/article/913836064-codexis-highlights-stereochemistry-advances-for-scalable-rna-manufacturing-at-tides-usa Iowa Healthcare Reporter en PressRelease 2026-05-20T13:00:00+00:00 Codexis highlights stereochemistry advances for scalable RNA manufacturing at TIDES USA https://ml.globenewswire.com/media/ebbfa755-c2db-4783-aace-43c700ba3369/small/codexis-logo-september-2023-png.png https://iowahealthcarereporter.com/article/913834611-just-salad-opens-in-north-babylon-n-y Iowa Healthcare Reporter en PressRelease 2026-05-20T12:57:00+00:00 Just Salad Opens in North Babylon, N.Y. https://ml.globenewswire.com/media/dd8f70d3-b483-4a82-a23a-9789def39a97/medium/just-salad-north-babylon-storefront.jpg https://iowahealthcarereporter.com/article/913834519-propanc-biopharma-s-ceo-forecasts-new-medical-breakthroughs-in-the-fight-against-pancreatic-cancer-over-the-next-decade Iowa Healthcare Reporter en PressRelease 2026-05-20T12:45:00+00:00 Propanc Biopharma’s CEO Forecasts New Medical Breakthroughs in the Fight Against Pancreatic Cancer Over the Next Decade https://ml.globenewswire.com/media/0de2a486-4708-45bf-a406-f462ad395dec/small/propanc-logo-png.png https://iowahealthcarereporter.com/article/913835684-ernexa-therapeutics-releases-virtual-investor-kol-connect-segment-featuring-dr-elena-ratner-highlighting-ovarian-cancer-landscape-and-erna-101 Iowa Healthcare Reporter en PressRelease 2026-05-20T12:31:00+00:00 Ernexa Therapeutics Releases Virtual Investor KOL Connect Segment Featuring Dr. Elena Ratner Highlighting Ovarian Cancer Landscape and ERNA-101 Opportunity https://ml.globenewswire.com/media/bb12f9ec-b7e7-4d8c-92df-cf27e238c398/small/ernexa-color-png.png https://iowahealthcarereporter.com/article/913834668-polypid-to-participate-in-the-craig-hallum-23rd-annual-institutional-investor-conference Iowa Healthcare Reporter en PressRelease 2026-05-20T12:30:00+00:00 PolyPid to Participate in the Craig-Hallum 23rd Annual Institutional Investor Conference https://ml.globenewswire.com/media/202fc254-aac1-49c2-a08d-cc0efc938460/small/polypid-logo-final-rgb-2x-100-jpg.jpg https://iowahealthcarereporter.com/article/913835158-stablecoin-development-corporation-reports-first-quarter-2026-financial-results Iowa Healthcare Reporter en PressRelease 2026-05-20T12:30:00+00:00 Stablecoin Development Corporation Reports First Quarter 2026 Financial Results https://ml.globenewswire.com/media/YTcyMTk0YjUtM2U4Yi00NDBiLWFjNjUtZTMyZTFjMjU1MTIwLTEwMjg2MTQtMjAyNi0wNS0yMC1lbg==/tiny/Stablecoin-Development-Corpora.png https://iowahealthcarereporter.com/article/913834741-sustainability-leader-ashley-mckeon-selected-as-soil-health-institute-s-president-and-ceo Iowa Healthcare Reporter en PressRelease 2026-05-20T12:15:00+00:00 Sustainability Leader Ashley McKeon Selected as Soil Health Institute’s President and CEO https://ml.globenewswire.com/media/02787cce-432b-4491-86ff-aa145be87ff4/medium/ashley-mckeon.png https://iowahealthcarereporter.com/article/913836632-pharmala-biotech-signs-term-sheet-to-license-exclusive-u-s-rights-to-ala-002-its-next-generation-mdma-therapeutic-to-jupiter-neurosciences-inc Iowa Healthcare Reporter en PressRelease 2026-05-20T12:15:00+00:00 PharmAla Biotech Signs Term Sheet to License Exclusive U.S. Rights to ALA-002, Its Next-Generation MDMA Therapeutic, to Jupiter Neurosciences, Inc. (NASDAQ: JUNS) in a Transaction Valued at Over $100 Million https://ml.globenewswire.com/media/20158980-8674-43e3-a0be-a10dca42410d/small/pharmala-biotech-logo-800-x-422-png.png https://iowahealthcarereporter.com/article/913834733-protara-therapeutics-to-present-at-the-td-cowen-7th-annual-oncology-innovation-summit-insights-for-asco-eha Iowa Healthcare Reporter en PressRelease 2026-05-20T12:00:00+00:00 Protara Therapeutics to Present at the TD Cowen 7th Annual Oncology Innovation Summit: Insights for ASCO & EHA https://ml.globenewswire.com/media/ba98d7ed-6917-452d-a864-6f60caa53c1b/small/protara-therapeutics-2x-png.png https://iowahealthcarereporter.com/article/913835079-madrigal-to-present-new-data-from-the-company-s-mash-program-at-easl-2026-demonstrating-the-effects-of-rezdiffra-on-markers-of-cardiovascular-and Iowa Healthcare Reporter en PressRelease 2026-05-20T12:00:00+00:00 Madrigal to Present New Data from the Company’s MASH Program at EASL 2026 Demonstrating the Effects of Rezdiffra on Markers of Cardiovascular and Portal Hypertension Risk https://ml.globenewswire.com/media/8fec8de1-1a2e-4f6c-a679-fc43002276ba/small/madrigal-logo-jpg.jpg https://iowahealthcarereporter.com/article/913835199-23andme-partners-with-healthex-to-connect-medical-records-with-your-dna-for-the-future-of-personalized-medicine Iowa Healthcare Reporter en PressRelease 2026-05-20T12:00:00+00:00 23andMe Partners with HealthEx to Connect Medical Records with Your DNA for the Future of Personalized Medicine https://ml.globenewswire.com/media/82f9b45c-015c-4db1-8f92-9d6ea1bae6be/medium/healthex-partnership-connects-medical-records-with-23andme.jpg https://iowahealthcarereporter.com/article/913835206-humacyte-announces-symvess-is-now-under-contract-with-the-strategic-acquisition-center-sac-of-the-u-s-department-of-veterans-affairs Iowa Healthcare Reporter en PressRelease 2026-05-20T12:00:00+00:00 Humacyte Announces Symvess® is Now Under Contract with the Strategic Acquisition Center (SAC) of the U.S. Department of Veterans Affairs https://ml.globenewswire.com/media/e81aff26-ead8-404d-aebb-159b45c3e7b1/small/huma-logo-png.png https://iowahealthcarereporter.com/article/913835869-phathom-pharmaceuticals-highlights-breadth-of-independent-vonoprazan-research-at-digestive-disease-week-2026-annual-meeting Iowa Healthcare Reporter en PressRelease 2026-05-20T12:00:00+00:00 Phathom Pharmaceuticals Highlights Breadth of Independent Vonoprazan Research at Digestive Disease Week 2026 Annual Meeting https://ml.globenewswire.com/media/0baa6f51-c6cb-4b21-a4e0-573a18b8171c/small/phathom-pharm-logo-jpg.jpg https://iowahealthcarereporter.com/article/913836085-gelteq-commences-veterinary-medicine-clinical-trial-to-support-an-fda-regulatory-pathway Iowa Healthcare Reporter en PressRelease 2026-05-20T12:00:00+00:00 Gelteq Commences Veterinary Medicine Clinical Trial to Support an FDA Regulatory Pathway https://ml.globenewswire.com/media/178e1a9c-f21e-4691-add7-b1398d96f7a6/small/gelteq-jpg.jpg https://iowahealthcarereporter.com/article/913836603-xchange-26-attendee-insights-highlight-healthcare-ai-s-shift-from-adoption-to-operational-scale Iowa Healthcare Reporter en PressRelease 2026-05-20T12:00:00+00:00 XCHANGE ‘26 Attendee Insights Highlight Healthcare AI’s Shift From Adoption to Operational Scale https://ml.globenewswire.com/media/71d3851d-9088-40ca-8ef6-3f420e7e3ef5/small/logo-xsolis-horizontal-navy-png.png https://iowahealthcarereporter.com/article/913836623-prenetics-announces-jay-shetty-as-im8-global-ambassador-and-shareholder-in-multi-year-partnership Iowa Healthcare Reporter en PressRelease 2026-05-20T12:00:00+00:00 Prenetics Announces Jay Shetty as IM8 Global Ambassador and Shareholder in Multi-Year Partnership https://ml.globenewswire.com/media/37ffe5e6-4c45-4e12-83bb-cfb9f70307a1/medium/jay-shetty-im8.jpg https://iowahealthcarereporter.com/article/913836650-annovis-announces-pricing-of-15-0-million-public-offering-of-common-stock-and-accompanying-warrants Iowa Healthcare Reporter en PressRelease 2026-05-20T12:00:00+00:00 Annovis Announces Pricing of $15.0 Million Public Offering of Common Stock and Accompanying Warrants https://ml.globenewswire.com/media/7ee459df-d33f-4f42-b27c-3bd20487d50c/small/annovis-corp-image-png.png https://iowahealthcarereporter.com/article/913836659-dyne-therapeutics-announces-initiation-of-phase-3-forzetto-trial-of-z-rostudirsen-in-duchenne-muscular-dystrophy-dmd-ahead-of-planned-bla-submission Iowa Healthcare Reporter en PressRelease 2026-05-20T11:46:18+00:00 Dyne Therapeutics Announces Initiation of Phase 3 FORZETTO Trial of Z-Rostudirsen in Duchenne Muscular Dystrophy (DMD) Ahead of Planned BLA Submission for U.S. Accelerated Approval https://ml.globenewswire.com/media/a9bc6e9f-f2a5-4129-978f-751f41a83728/medium/forzetto.png https://iowahealthcarereporter.com/article/913835708-lung-health-foundation-says-canada-s-current-access-system-to-emerging-therapies-is-moving-slower-than-modern-medicine Iowa Healthcare Reporter en PressRelease 2026-05-20T11:45:00+00:00 Lung Health Foundation Says Canada’s Current Access System to Emerging Therapies is Moving Slower than Modern Medicine https://ml.globenewswire.com/media/58a138ed-9f59-4520-98a9-1e68ebed4f05/small/lhf-primarylogo-rgb-150dpi-002-orig-png.png https://iowahealthcarereporter.com/article/913836646-jupiter-neurosciences-secures-100m-term-sheet-for-exclusive-u-s-rights-to-ala-002-a-next-generation-mdma-therapeutic-from-pharmala-biotech Iowa Healthcare Reporter en PressRelease 2026-05-20T11:38:00+00:00 Jupiter Neurosciences Secures $100M Term Sheet for Exclusive U.S. Rights to ALA-002, a Next-Generation MDMA Therapeutic from PharmAla Biotech https://ml.globenewswire.com/media/4e829d7e-ecf6-46ad-98fe-479755d626e1/small/image-png.png https://iowahealthcarereporter.com/article/913836034-kraig-biocraft-laboratories-highlights-technical-breakthrough-of-its-immortalized-silk-gland-cell-platform Iowa Healthcare Reporter en PressRelease 2026-05-20T11:35:00+00:00 Kraig Biocraft Laboratories Highlights Technical Breakthrough of Its Immortalized Silk Gland Cell Platform https://ml.globenewswire.com/media/c5c0ab91-d30a-423a-b5e9-b4e2ac827c3d/medium/kraig-labs-scientific-team-immortalizes-silk-gland-cell.png https://iowahealthcarereporter.com/article/913836583-repligen-announces-publication-of-the-company-s-2025-corporate-sustainability-report Iowa Healthcare Reporter en PressRelease 2026-05-20T11:30:00+00:00 Repligen Announces Publication of the Company’s 2025 Corporate Sustainability Report https://ml.globenewswire.com/media/967d43f6-7ffd-4ee0-8804-e3c12952402f/small/repligen-logo-horizontal-withtagline-1-jpg.jpg https://iowahealthcarereporter.com/article/913836635-emergent-biosolutions-to-participate-in-upcoming-investor-conferences Iowa Healthcare Reporter en PressRelease 2026-05-20T11:30:00+00:00 Emergent BioSolutions to Participate in Upcoming Investor Conferences https://ml.globenewswire.com/media/56a9097d-af91-4bcf-8c42-5905e1614ef1/small/emerge-png.png https://iowahealthcarereporter.com/article/913836601-medline-inc-announces-launch-of-secondary-offering-of-class-a-common-stock Iowa Healthcare Reporter en PressRelease 2026-05-20T11:10:41+00:00 Medline Inc. announces launch of secondary offering of Class A common stock https://ml.globenewswire.com/media/70e45830-32e3-4232-b15b-7e43c436de41/small/log-medline-1200-630-center-png.png https://iowahealthcarereporter.com/article/913834361-4basebio-signs-clinical-supply-agreement-to-support-phase-ii-clinical-trial Iowa Healthcare Reporter en PressRelease 2026-05-20T11:00:00+00:00 4basebio Signs Clinical Supply Agreement to Support Phase II Clinical Trial https://ml-eu.globenewswire.com/media/b4cdfb28-5792-4f0a-b80f-b960556fe025/small/4basebio-logo-1-png.png https://iowahealthcarereporter.com/article/913834365-final-results-and-notice-of-agm Iowa Healthcare Reporter en PressRelease 2026-05-20T11:00:00+00:00 Final Results and Notice of AGM https://ml-eu.globenewswire.com/media/b4cdfb28-5792-4f0a-b80f-b960556fe025/small/4basebio-logo-1-png.png https://iowahealthcarereporter.com/article/913834601-syndax-announces-participation-in-upcoming-investor-conferences Iowa Healthcare Reporter en PressRelease 2026-05-20T11:00:00+00:00 Syndax Announces Participation in Upcoming Investor Conferences https://ml.globenewswire.com/media/399a65b5-bd4f-4ba5-980b-f4d0af9ae6a0/small/syndax-logo-jpg.jpg https://iowahealthcarereporter.com/article/913834766-why-biotech-companies-are-replacing-national-gas-suppliers-with-agile-regional-partners-in-2026 Iowa Healthcare Reporter en PressRelease 2026-05-20T11:00:00+00:00 Why Biotech Companies Are Replacing National Gas Suppliers With Agile Regional Partners in 2026 https://ml.globenewswire.com/media/54f68786-45fe-483a-944a-10d2ef6d7baf/small/westair-logo-png.png https://iowahealthcarereporter.com/article/913834799-monte-rosa-therapeutics-to-participate-in-upcoming-investor-conferences Iowa Healthcare Reporter en PressRelease 2026-05-20T11:00:00+00:00 Monte Rosa Therapeutics to Participate in Upcoming Investor Conferences https://ml.globenewswire.com/media/20ed9999-454a-4e2a-aabc-217270a87d2d/small/mrtx-logo-primaryblue-4cp-jpg.jpg https://iowahealthcarereporter.com/article/913835070-netramark-to-present-at-the-american-society-of-clinical-psychopharmacology-annual-meeting Iowa Healthcare Reporter en PressRelease 2026-05-20T11:00:00+00:00 NetraMark to Present at the American Society of Clinical Psychopharmacology Annual Meeting https://ml.globenewswire.com/media/d65cf3f8-cf9c-475c-b740-09a659269da4/small/netramark-word-eye-blk-jpg.jpg https://iowahealthcarereporter.com/article/913835195-ichnos-glenmark-innovation-igi-announces-new-development-candidate-isb-2301-a-first-in-class-multispecific-immune-cells-activator-targeting-solid Iowa Healthcare Reporter en PressRelease 2026-05-20T11:00:00+00:00 Ichnos Glenmark Innovation (IGI) Announces New Development Candidate, ISB 2301, a First-in-Class Multispecific Immune Cells Activator Targeting Solid Tumors https://ml.globenewswire.com/media/1efc56d9-10ca-47f6-b389-0f549311aa9e/small/igi-ichnos-glenmark-innovation-logo-png.png https://iowahealthcarereporter.com/article/913835355-c4-therapeutics-to-participate-in-upcoming-conferences Iowa Healthcare Reporter en PressRelease 2026-05-20T11:00:00+00:00 C4 Therapeutics to Participate in Upcoming Conferences https://ml.globenewswire.com/media/50045422-c7cb-42b0-857a-1f69f1efc0a6/small/c4therapeutics-website-logo-fullcolor-r-png.png https://iowahealthcarereporter.com/article/913835910-blossomhill-therapeutics-expands-board-of-directors-with-the-appointments-of-sheila-gujrathi-m-d-and-john-schmid Iowa Healthcare Reporter en PressRelease 2026-05-20T11:00:00+00:00 BlossomHill Therapeutics Expands Board of Directors with the Appointments of Sheila Gujrathi, M.D., and John Schmid  https://ml.globenewswire.com/media/02f747e9-636d-467e-81f8-d942e9421158/small/blossomhill-vertical-fullcolor-cmyk1-jpg.jpg https://iowahealthcarereporter.com/article/913836003-skye-announces-cohort-review-committee-approved-opening-of-cohort-2-based-on-favorable-safety-data-from-first-four-participants-treated-in-cohort-1 Iowa Healthcare Reporter en PressRelease 2026-05-20T11:00:00+00:00 Skye Announces Cohort Review Committee Approved Opening of Cohort 2 Based on Favorable Safety Data from First Four Participants Treated in Cohort 1 https://ml.globenewswire.com/media/905e06d8-af43-4f7a-b097-8c12ce1d3aa0/small/skye-darkblue-jpg.jpg https://iowahealthcarereporter.com/article/913836053-immunovant-provides-corporate-updates-and-reports-financial-results-for-the-fourth-quarter-and-fiscal-year-ended-march-31-2026 Iowa Healthcare Reporter en PressRelease 2026-05-20T11:00:00+00:00 Immunovant Provides Corporate Updates and Reports Financial Results for the Fourth Quarter and Fiscal Year Ended March 31, 2026 https://ml.globenewswire.com/media/7062c765-82cc-4ba2-ba1f-4b1396b9b052/small/immulogo-jpg.jpg https://iowahealthcarereporter.com/article/913836056-roivant-reports-financial-results-for-the-fourth-quarter-and-fiscal-year-ended-march-31-2026-and-provides-business-update Iowa Healthcare Reporter en PressRelease 2026-05-20T11:00:00+00:00 Roivant Reports Financial Results for the Fourth Quarter and Fiscal Year Ended March 31, 2026 and Provides Business Update https://ml.globenewswire.com/media/f1a5db68-ee4f-437f-b4e6-2b840ae6a536/small/roivantlogo-png.png https://iowahealthcarereporter.com/article/913836438-zoomrx-launches-sagan-agents-the-ai-operating-system-purpose-built-to-agentify-any-pharma-customer-insights-workflow Iowa Healthcare Reporter en PressRelease 2026-05-20T11:00:00+00:00 ZoomRx launches Sagan Agents, the AI operating system purpose-built to agentify any pharma customer insights workflow https://ml.globenewswire.com/media/d4f29735-65dd-4876-bb74-39e063c64fcc/small/sagan-agents-black-png.png https://iowahealthcarereporter.com/article/913836546-grey-matters-health-signs-loi-with-catalyst-medtech-for-200-brain-pet-scans-for-alzheimer-s-clinical-trial-at-2nd-novascan-location-planned-for-tampa Iowa Healthcare Reporter en PressRelease 2026-05-20T11:00:00+00:00 Grey Matters Health Signs LOI with Catalyst MedTech for 200 Brain PET Scans for Alzheimer’s Clinical Trial at 2nd NovaScan Location Planned for Tampa https://ml.globenewswire.com/media/fa49f075-8db6-4fbc-b1da-8e710a9d4235/medium/novascan-neuroimaging-clinics.jpg https://iowahealthcarereporter.com/article/913835915-avricore-health-announces-1-25-million-financing Iowa Healthcare Reporter en PressRelease 2026-05-20T10:55:00+00:00 Avricore Health Announces $1.25 Million Financing https://ml.globenewswire.com/media/a3e47a88-fedc-4db4-969f-5fe1f028c54a/small/avicorelogo-png.png https://iowahealthcarereporter.com/article/913810443-un-essai-clinique-canadien-sans-pr-c-dent-value-des-comprim-s-de-selles-pour-am-liorer-l-immunoth-rapie-du-cancer-du-poumon Iowa Healthcare Reporter en PressRelease 2026-05-20T10:34:25+00:00 Un essai clinique canadien sans précédent évalue des « comprimés de selles » pour améliorer l’immunothérapie du cancer du poumon https://ml.globenewswire.com/media/MDcyMzc5OWYtNGRlMi00NmY0LWI0MTUtYTI3YTkzZmRhNmEzLTUwMDExMzcxNy0yMDI2LTA1LTIwLWZy/tiny/Weston-Family-Foundation.png https://iowahealthcarereporter.com/article/913810467-largest-ever-canadian-clinical-trial-tests-poop-pills-to-improve-immunotherapy-for-lung-cancer Iowa Healthcare Reporter en PressRelease 2026-05-20T10:34:25+00:00 Largest-ever Canadian clinical trial tests “poop pills” to improve immunotherapy for lung cancer https://ml.globenewswire.com/media/NzUyMTIxM2YtMTdiNC00NTk3LTg5MjktMTIyM2EwYzMzNzRhLTUwMDExMzcxNy0yMDI2LTA1LTIwLWVu/tiny/Weston-Family-Foundation.png https://iowahealthcarereporter.com/article/913810224-pacira-biosciences-files-investor-presentation-highlighting-successful-execution-of-its-long-term-strategy-to-drive-value-for-all-stockholders Iowa Healthcare Reporter en PressRelease 2026-05-20T10:30:00+00:00 Pacira BioSciences Files Investor Presentation Highlighting Successful Execution of its Long-Term Strategy to Drive Value for All Stockholders https://ml.globenewswire.com/media/3e502c92-e576-46b6-b602-a177ab0f5044/small/pacira-biosciences-tm-logo-rgb-v2025-300dpi-adj-png.png https://iowahealthcarereporter.com/article/913810286-corvel-announces-revenues-and-earnings Iowa Healthcare Reporter en PressRelease 2026-05-20T10:15:00+00:00 CorVel Announces Revenues and Earnings https://ml.globenewswire.com/media/dc150059-2d36-47de-9f10-e6f5990ba046/small/corvel-primary-full-color-png.png https://iowahealthcarereporter.com/article/913810300-belite-bio-reports-unaudited-first-quarter-2026-financial-results-and-provides-a-corporate-update Iowa Healthcare Reporter en PressRelease 2026-05-20T10:00:00+00:00 Belite Bio Reports Unaudited First Quarter 2026 Financial Results and Provides a Corporate Update https://ml.globenewswire.com/media/7f86ac70-6347-41c6-a622-e7000c42ad35/small/belite-bio-logo-digital-full-color-png.png https://iowahealthcarereporter.com/article/913810423-hiwell-absorfyx-berberine-with-ceylon-cinnamon-a-modern-approach-to-daily-metabolic-wellness-and-weight-management-support Iowa Healthcare Reporter en PressRelease 2026-05-20T09:37:54+00:00 HiWell Absorfyx Berberine with Ceylon Cinnamon: A Modern Approach to Daily Metabolic Wellness and Weight Management Support https://ml.globenewswire.com/media/12bc8091-fb3e-4454-bd78-437710efb91a/medium/hiwell-absorfyx-formula-per-2-capsules-berberine-300mg-ceylo.png https://iowahealthcarereporter.com/article/913810336-winner-medical-breaks-ground-on-new-production-base-in-vietnam-to-serve-global-medical-supply-chains-through-local-manufacturing Iowa Healthcare Reporter en PressRelease 2026-05-20T08:28:38+00:00 Winner Medical Breaks Ground on New Production Base in Vietnam to Serve Global Medical Supply Chains Through Local Manufacturing https://ml.globenewswire.com/media/0b41efe6-06e6-46af-b13f-c2d26d36d16d/medium/image-1.jpeg https://iowahealthcarereporter.com/article/913788145-serb-pharmaceuticals-erwirbt-von-hansa-biopharma-europ-ische-und-mena-rechte-an-idefirix-imlifidase-f-r-115-mio Iowa Healthcare Reporter en PressRelease 2026-05-20T05:51:38+00:00 SERB Pharmaceuticals erwirbt von Hansa Biopharma europäische und MENA-Rechte an Idefirix® (Imlifidase) für 115 Mio. € https://ml.globenewswire.com/media/NGY2ZjhiYTAtYjMyMS00M2E4LWI2ODUtZjE5YmNiMTk5YTlhLTUwMDE1NTM3MC0yMDI2LTA1LTIwLWRl/tiny/SERB-Pharmaceuticals.png https://iowahealthcarereporter.com/article/913788153-serb-pharmaceuticals-acquiert-aupr-s-de-hansa-biopharma-les-droits-europ-ens-et-mena-d-idefirix-imlifidase-pour-115-millions-d-euros Iowa Healthcare Reporter en PressRelease 2026-05-20T05:51:38+00:00 SERB Pharmaceuticals acquiert auprès de Hansa Biopharma les droits européens et MENA d’Idefirix® (imlifidase) pour 115 millions d’euros https://ml.globenewswire.com/media/NGY2ZjhiYTAtYjMyMS00M2E4LWI2ODUtZjE5YmNiMTk5YTlhLTUwMDE1NTM3MC0yMDI2LTA1LTIwLWZy/tiny/SERB-Pharmaceuticals.png https://iowahealthcarereporter.com/article/913767210-synendos-therapeutics-starts-phase-2-trial-in-generalized-anxiety-disorder Iowa Healthcare Reporter en PressRelease 2026-05-20T05:30:00+00:00 Synendos Therapeutics Starts Phase 2 Trial in Generalized Anxiety Disorder https://ml-eu.globenewswire.com/media/9a6e58ee-f37d-4ff6-ba7b-3296827b2348/medium/professor-allan-young.png https://iowahealthcarereporter.com/article/913742811-shiny-smile-veneers-claims-evaluated-2026-consumer-report-update-critical-complaints-investigated Iowa Healthcare Reporter en PressRelease 2026-05-20T01:23:45+00:00 Shiny Smile Veneers Claims Evaluated (2026 Consumer Report Update) Critical Complaints Investigated https://zingfast.com/wp-content/uploads/2026/05/Shiny-Smile-Veneers-Complaints.jpg https://iowahealthcarereporter.com/article/913742796-java-tide-critical-assessment-the-gelatin-ice-trick-before-bed-using-the-java-tide-formula-recipe Iowa Healthcare Reporter en PressRelease 2026-05-20T01:04:03+00:00 Java Tide Critical Assessment: The Gelatin Ice Trick Before Bed Using the Java Tide Formula Recipe https://zingfast.com/wp-content/uploads/2026/05/Java-Tide-2.jpg https://iowahealthcarereporter.com/article/913718020-slimtide-claims-evaluated-the-baking-soda-water-shot-gelatin-trick-for-losing-weight-naturally-by-slim-tide Iowa Healthcare Reporter en PressRelease 2026-05-19T23:59:41+00:00 SlimTide Claims Evaluated: The Baking Soda Water Shot Gelatin Trick for Losing Weight Naturally by Slim Tide https://zingfast.com/wp-content/uploads/2026/05/SlimTide-1.jpg https://iowahealthcarereporter.com/article/913694193-monopar-announces-publication-of-phase-2-study-demonstrating-alxn1840-significantly-improves-copper-balance-in-patients-with-wilson-disease Iowa Healthcare Reporter en PressRelease 2026-05-19T21:33:00+00:00 Monopar Announces Publication of Phase 2 Study Demonstrating ALXN1840 Significantly Improves Copper Balance in Patients with Wilson Disease https://ml.globenewswire.com/media/f8cee181-5ae9-4a02-84f5-6e35affbb72b/small/monopartherapeuticsinc-png.png https://iowahealthcarereporter.com/article/913693831-aura-biosciences-announces-inducement-grants-under-nasdaq-listing-rule-5635-c-4 Iowa Healthcare Reporter en PressRelease 2026-05-19T20:50:52+00:00 Aura Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) https://ml.globenewswire.com/media/92103c30-8e5a-4502-9ec4-0f3b3bd9bb83/small/aura-biosciences-1c-orange-large-jpg.jpg https://iowahealthcarereporter.com/article/913693815-journey-medical-corporation-to-participate-in-a-g-p-s-annual-virtual-healthcare-conference Iowa Healthcare Reporter en PressRelease 2026-05-19T20:45:00+00:00 Journey Medical Corporation to Participate in A.G.P.’s Annual Virtual Healthcare Conference https://ml.globenewswire.com/media/68f0b467-248f-4250-9cda-2c7a68a11a1d/small/journeylogo-1-jpg.jpg https://iowahealthcarereporter.com/article/913693217-olema-oncology-to-participate-in-upcoming-investor-conferences Iowa Healthcare Reporter en PressRelease 2026-05-19T20:30:00+00:00 Olema Oncology to Participate in Upcoming Investor Conferences https://ml.globenewswire.com/media/9c736753-c905-4bd1-ac3a-1444bea84331/small/olema-logo-rgb-png.png https://iowahealthcarereporter.com/article/913693284-eton-pharmaceuticals-expands-rare-disease-portfolio-through-agreement-for-u-s-commercialization-rights-to-impavido-miltefosine Iowa Healthcare Reporter en PressRelease 2026-05-19T20:30:00+00:00 Eton Pharmaceuticals Expands Rare Disease Portfolio Through Agreement for U.S. Commercialization Rights to IMPAVIDO® (miltefosine) https://ml.globenewswire.com/media/db07cafa-b35c-4d61-a1a1-d330caf67ad2/small/eton-logo-png.png https://iowahealthcarereporter.com/article/913693608-cadrenal-therapeutics-to-participate-in-the-lytham-partners-spring-2026-investor-conference-on-may-28-2026 Iowa Healthcare Reporter en PressRelease 2026-05-19T20:30:00+00:00 Cadrenal Therapeutics to Participate in the Lytham Partners Spring 2026 Investor Conference on May 28, 2026 https://ml.globenewswire.com/media/dec0fe5d-b262-4ca7-94e0-1fd3856d07a8/small/cvkd-logo-2025-png.png https://iowahealthcarereporter.com/article/913693704-ozari-health-launches-nationwide-telehealth-platform-for-compounded-semaglutide-and-tirzepatide-starting-at-86-per-month Iowa Healthcare Reporter en PressRelease 2026-05-19T20:15:00+00:00 Ozari Health Launches Nationwide Telehealth Platform for Compounded Semaglutide and Tirzepatide Starting at $86 Per Month https://pressranger.s3.us-west-1.amazonaws.com/3292406/Untitled-design-%283%29.png https://iowahealthcarereporter.com/article/913693269-rxsight-inc-to-present-at-the-stifel-2026-virtual-ophthalmology-forum Iowa Healthcare Reporter en PressRelease 2026-05-19T20:10:00+00:00 RxSight, Inc. to Present at the Stifel 2026 Virtual Ophthalmology Forum https://ml.globenewswire.com/media/48441335-c938-45ff-9355-ba8e331354e9/small/rxsight-globe-png.png https://iowahealthcarereporter.com/article/913693728-annovis-announces-launch-of-proposed-public-offering-of-common-stock-and-accompanying-warrants Iowa Healthcare Reporter en PressRelease 2026-05-19T20:06:26+00:00 Annovis Announces Launch of Proposed Public Offering of Common Stock and Accompanying Warrants https://ml.globenewswire.com/media/7ee459df-d33f-4f42-b27c-3bd20487d50c/small/annovis-corp-image-png.png https://iowahealthcarereporter.com/article/913693193-alps-group-inc-announces-receipt-of-nasdaq-notification-regarding-minimum-bid-price-deficiency Iowa Healthcare Reporter en PressRelease 2026-05-19T20:05:00+00:00 Alps Group Inc Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency https://ml.globenewswire.com/media/ce232220-dc3f-4308-a2b7-f695be7b9f0b/small/alps-global-holding-berhad-logo-01-png.png https://iowahealthcarereporter.com/article/913693214-iridex-reports-first-quarter-2026-financial-results Iowa Healthcare Reporter en PressRelease 2026-05-19T20:05:00+00:00 Iridex Reports First Quarter 2026 Financial Results https://ml.globenewswire.com/media/2bb80159-a920-428b-aa69-c2f32e3038c9/small/iridex-corporate-logo-horizontal-rgb-m02-jpg.jpg https://iowahealthcarereporter.com/article/913693273-resmed-announces-participation-in-the-46th-annual-william-blair-growth-stock-conference Iowa Healthcare Reporter en PressRelease 2026-05-19T20:05:00+00:00 Resmed Announces Participation in the 46th Annual William Blair Growth Stock Conference https://ml.globenewswire.com/media/fb7a34f4-d074-4bcf-b827-7a6a60924c46/small/resmed-h-pos-clr-rgb-250121-png.png https://iowahealthcarereporter.com/article/913693277-suja-life-to-report-first-quarter-2026-financial-results-on-june-9-2026 Iowa Healthcare Reporter en PressRelease 2026-05-19T20:05:00+00:00 Suja Life to Report First Quarter 2026 Financial Results on June 9, 2026 https://ml.globenewswire.com/media/9022887d-dd69-416f-9a4b-ce5e546d75e4/small/suja-life-horizontal-black-1-png.png https://iowahealthcarereporter.com/article/913693488-artiva-biotherapeutics-announces-multiple-allonk-data-presentations-at-eular-2026-congress-including-late-breaking-oral-presentation-highlighting Iowa Healthcare Reporter en PressRelease 2026-05-19T20:05:00+00:00 Artiva Biotherapeutics Announces Multiple AlloNK® Data Presentations at EULAR 2026 Congress, Including Late-Breaking Oral Presentation Highlighting Clinical Efficacy Comparable to Autologous CAR T-Cell Therapy in Rheumatologic Diseases https://ml.globenewswire.com/media/0392544b-ecff-4590-9eed-59c934e1ba4d/small/artiva-biotherapeutics-logo-jpg.jpg https://iowahealthcarereporter.com/article/913693615-nurexone-receives-notice-of-patent-grant-in-south-korea-covering-exopten-technology Iowa Healthcare Reporter en PressRelease 2026-05-19T20:04:00+00:00 NurExone Receives Notice of Patent Grant in South Korea Covering ExoPTEN Technology https://ml.globenewswire.com/media/1514c671-cc84-4bcb-82d7-b834fce40882/small/nurexone-logo-rebrand-large-png.png https://iowahealthcarereporter.com/article/913693629-relay-therapeutics-announces-proposed-public-offering-of-common-stock Iowa Healthcare Reporter en PressRelease 2026-05-19T20:03:00+00:00 Relay Therapeutics Announces Proposed Public Offering of Common Stock https://ml.globenewswire.com/media/079b6db5-ce81-4a81-9cde-d97f86c569ae/small/logo-banner-small-png.png https://iowahealthcarereporter.com/article/913693235-kura-oncology-to-present-at-td-cowen-7th-annual-oncology-innovation-summit Iowa Healthcare Reporter en PressRelease 2026-05-19T20:02:00+00:00 Kura Oncology to Present at TD Cowen 7th Annual Oncology Innovation Summit https://ml.globenewswire.com/media/ebf510d7-3727-4cc8-894f-6ce2d82b941a/small/kura-logo-for-globe-newswire-prs-png.png https://iowahealthcarereporter.com/article/913693696-vaxart-files-preliminary-proxy-statement-and-issues-open-letter-to-shareholders Iowa Healthcare Reporter en PressRelease 2026-05-19T20:01:00+00:00 Vaxart Files Preliminary Proxy Statement and Issues Open Letter to Shareholders https://ml.globenewswire.com/media/aedaf06c-26f8-482c-ac72-39774eab2c35/small/vxrt-logo-jpg.png https://iowahealthcarereporter.com/article/913693594-sol-sence-day-mode-hero-concealer-spf-50-wins-three-categories-at-the-2026-cosmetics-toiletries-all-awards-marking-fourth-year-of-recognition Iowa Healthcare Reporter en PressRelease 2026-05-19T19:31:49+00:00 Solésence Day Mode Hero Concealer SPF 50+ Wins Three Categories at the 2026 Cosmetics & Toiletries Allē Awards, Marking Fourth Year of Recognition https://ml.globenewswire.com/media/cd3e5e4e-9567-4a86-8f44-900ffeb29d33/small/solesence-fullcolor-300dpi-social-002-1-png.png https://iowahealthcarereporter.com/article/913669891-ipsen-announces-late-breaking-data-from-first-head-to-head-study-comparing-dysport-and-botox-in-adults-with-upper-limb-spasticity Iowa Healthcare Reporter en PressRelease 2026-05-19T19:00:00+00:00 Ipsen announces late-breaking data from first head-to-head study comparing Dysport® and Botox® in adults with upper limb spasticity https://ml-eu.globenewswire.com/media/81292fcc-6b3a-4e4a-a083-ea4191bf920a/small/ipsen-notified-website-1200x628pix-500kb-max-jpg.jpg https://iowahealthcarereporter.com/article/913669898-ipsen-annonce-des-donn-es-late-breaking-issues-de-la-premi-re-tude-comparative-directe-entre-dysport-et-botox-chez-des-adultes-atteints-de Iowa Healthcare Reporter en PressRelease 2026-05-19T19:00:00+00:00 Ipsen annonce des données « late-breaking » issues de la première étude comparative directe entre Dysport® et Botox® chez des adultes atteints de spasticité du membre supérieur https://ml-eu.globenewswire.com/media/81292fcc-6b3a-4e4a-a083-ea4191bf920a/small/ https://iowahealthcarereporter.com/article/913669926-oorja-bio-launches-as-a-clinical-stage-company-to-develop-groundbreaking-therapies-for-idiopathic-pulmonary-fibrosis-ipf-and-other-fibrotic-diseases Iowa Healthcare Reporter en PressRelease 2026-05-19T19:00:00+00:00 Oorja Bio Launches as a Clinical-Stage Company to Develop Groundbreaking Therapies for Idiopathic Pulmonary Fibrosis (IPF) and Other Fibrotic Diseases https://ml.globenewswire.com/media/13c2e486-08d9-4c2a-96bf-2775b89ac959/small/oorja-bio-logo-png.png https://iowahealthcarereporter.com/article/913669952-oorja-bio-unveils-clinical-data-for-orj-001-a-first-in-class-therapeutic-targeting-alveolar-epithelial-type-2-aec2-cells-for-treatment-of Iowa Healthcare Reporter en PressRelease 2026-05-19T19:00:00+00:00 Oorja Bio Unveils Clinical Data for ORJ-001, a First-in-Class Therapeutic Targeting Alveolar Epithelial Type 2 (AEC2) Cells for Treatment of Idiopathic Pulmonary Fibrosis (IPF) https://ml.globenewswire.com/media/13c2e486-08d9-4c2a-96bf-2775b89ac959/small/oorja-bio-logo-png.png https://iowahealthcarereporter.com/article/913669979-hemet-global-medical-center-announces-new-ambulance-bay-ems-lounge-and-cardiovascular-operating-room-during-2026-ems-week Iowa Healthcare Reporter en PressRelease 2026-05-19T17:18:44+00:00 Hemet Global Medical Center Announces New Ambulance Bay, EMS Lounge, and Cardiovascular Operating Room During 2026 EMS Week https://ml.globenewswire.com/media/52732ed2-c81b-4663-b6ea-6c1887b48c51/medium/hemet-global-medical-center-facility-upgrades-unveiled.jpeg https://iowahealthcarereporter.com/article/913648629-fantastic-services-unveils-new-report-warning-private-landlords-over-rising-legal-exposure-to-damp-and-mould-claims Iowa Healthcare Reporter en PressRelease 2026-05-19T16:32:00+00:00 Fantastic Services Unveils New Report Warning Private Landlords Over Rising Legal Exposure to Damp and Mould Claims https://pressranger.s3.us-west-1.amazonaws.com/3290992/Before-after-image-for-mould-press-release.jpg https://iowahealthcarereporter.com/article/913648816-altitude-lab-portfolio-companies-surpass-205-million-in-funding-marking-a-new-era-for-early-stage-biotechs-in-salt-lake-city Iowa Healthcare Reporter en PressRelease 2026-05-19T16:07:00+00:00 Altitude Lab Portfolio Companies Surpass $205 Million in Funding, Marking a New Era for Early-Stage Biotechs in Salt Lake City https://ml.globenewswire.com/media/8e0ac14b-aaee-44e1-8d45-6e131f8cef66/small/png-altitude-lab-black-color-40-1-png.png https://iowahealthcarereporter.com/article/913648796-virginia-beach-teen-finds-new-confidence-after-chest-wall-reconstruction-at-children-s-hospital-of-the-king-s-daughters-chkd-nuss-center Iowa Healthcare Reporter en PressRelease 2026-05-19T15:57:33+00:00 Virginia Beach teen finds new confidence after chest wall reconstruction at Children's Hospital of The King's Daughters (CHKD) Nuss Center https://ml.globenewswire.com/media/MWJkNjI2OWUtNzY5Ni00ZmYyLWJkYTYtZGNlMWY1YjgxYTZiLTEyNzQwOTAtMjAyNi0wNS0xOS1lbg==/tiny/Children-s-Hospital-of-The-Kin.png https://iowahealthcarereporter.com/article/913648494-nord-pilates-surpasses-1-300-customer-reviews-as-women-praise-personalized-pilates-plans-and-low-impact-home-workouts Iowa Healthcare Reporter en PressRelease 2026-05-19T15:12:08+00:00 Nord Pilates Surpasses 1,300 Customer Reviews as Women Praise Personalized Pilates Plans and Low-Impact Home Workouts https://ml-eu.globenewswire.com/media/afc8c536-7e7c-4ca3-b9fe-98c14ee3156e/medium/nord-pilates.png https://iowahealthcarereporter.com/article/913648638-atos-selected-by-viasat-to-modernize-global-digital-workplace-operations Iowa Healthcare Reporter en PressRelease 2026-05-19T15:09:17+00:00 Atos Selected by Viasat to Modernize Global Digital Workplace Operations https://ml.globenewswire.com/media/3eacc37c-6163-4d11-95aa-944fca92da46/small/atos-logo-blue-rgb-png.png https://iowahealthcarereporter.com/article/913648569-dandy-celery-launches-stars-stripes-dandy-bites-sweepstakes Iowa Healthcare Reporter en PressRelease 2026-05-19T14:47:00+00:00 DANDY® CELERY LAUNCHES STARS, STRIPES & DANDY BITES” SWEEPSTAKES https://ml.globenewswire.com/media/NDMzNjI2ZDMtZGVhOC00NDYxLTgwYTgtMjEyOWFjNzY3MmJhLTExMDA0ODQtMjAyNi0wNS0xOS1lbg==/tiny/Duda-Farm-Fresh-Foods.png https://iowahealthcarereporter.com/article/913628941-neonc-technologies-gains-growing-institutional-support-ahead-of-key-brain-cancer-clinical-milestones Iowa Healthcare Reporter en PressRelease 2026-05-19T14:28:20+00:00 NeOnc Technologies Gains Growing Institutional Support Ahead of Key Brain Cancer Clinical Milestones https://ml.globenewswire.com/media/1f91276c-d820-4666-8efc-2d8786490903/small/neonc-technologies-holding-logo-vector-png.png https://iowahealthcarereporter.com/article/913628904-capra-biosciences-launches-bioproduced-salicylic-acid-for-personal-care-at-nyscc-suppliers-day Iowa Healthcare Reporter en PressRelease 2026-05-19T14:21:27+00:00 Capra Biosciences Launches Bioproduced Salicylic Acid for Personal Care at NYSCC Suppliers’ Day https://ml.globenewswire.com/media/c134cc56-07a9-459d-a32c-446a66599e93/small/logolightbackground-png.png https://iowahealthcarereporter.com/article/913627642-enspire-dental-launches-new-emergency-care-initiative-to-assist-ann-arbor-families-during-dental-crises Iowa Healthcare Reporter en PressRelease 2026-05-19T14:00:00+00:00 Enspire Dental Launches New Emergency Care Initiative to Assist Ann Arbor Families During Dental Crises https://pressranger.s3.us-west-1.amazonaws.com/3291418/enspire-dental-ann-arbor-luxury-office-lobby.jpeg https://iowahealthcarereporter.com/article/913627688-ama-names-dr-john-wigneswaran-as-chief-operating-officer Iowa Healthcare Reporter en PressRelease 2026-05-19T14:00:00+00:00 AMA Names Dr. John Wigneswaran as Chief Operating Officer https://ml.globenewswire.com/media/MmMxMTIwNjMtNTYyMC00NjVkLThmZTAtZjY3N2MyZDc0MjA1LTEwOTg0MDUtMjAyNi0wNS0xOS1lbg==/tiny/American-Medical-Association.png https://iowahealthcarereporter.com/article/913628797-biosyent-announces-health-canada-approval-of-thyconvi-levothyroxine-oral-solution Iowa Healthcare Reporter en PressRelease 2026-05-19T13:52:59+00:00 BioSyent Announces Health Canada Approval of Thyconvi™ (levothyroxine oral solution) https://ml.globenewswire.com/media/3dded277-7953-4418-be63-7d7a3067811d/small/biosyent-logo-png.png https://iowahealthcarereporter.com/article/913628799-biosyent-annonce-l-approbation-de-thyconvi-md-par-sant-canada-solution-orale-de-l-vothyroxine Iowa Healthcare Reporter en PressRelease 2026-05-19T13:52:59+00:00 BioSyent annonce l’approbation de Thyconvi(MD) par Santé Canada (solution orale de lévothyroxine) https://ml.globenewswire.com/media/3dded277-7953-4418-be63-7d7a3067811d/small/biosyent-logo-png.png https://iowahealthcarereporter.com/article/913628778-global-virus-network-experts-urge-rapid-regional-action-as-bundibugyo-ebola-outbreak-raises-cross-border-concerns Iowa Healthcare Reporter en PressRelease 2026-05-19T13:46:54+00:00 Global Virus Network Experts Urge Rapid Regional Action as Bundibugyo Ebola Outbreak Raises Cross-Border Concerns https://ml.globenewswire.com/media/6c1b2724-7b9b-469a-a7c3-bc0a64d716ae/small/gvn-lt-gr-gradiant-jpg.jpg https://iowahealthcarereporter.com/article/913628377-dyadic-applied-biosolutions-announces-participation-in-sidoti-virtual-investor-conference Iowa Healthcare Reporter en PressRelease 2026-05-19T13:35:00+00:00 Dyadic Applied BioSolutions Announces Participation in Sidoti Virtual Investor Conference https://ml.globenewswire.com/media/c67f7901-660b-41c0-a160-0f92fd04bb42/small/dyadic-applied-biosolutions-jpg.jpg https://iowahealthcarereporter.com/article/913628743-latest-healthcare-provider-network-management-market-size-will-attain-usd-12-48-billion-by-2034-growing-at-11-20-cagr-exclusive-report-by-zmr Iowa Healthcare Reporter en PressRelease 2026-05-19T13:22:51+00:00 [Latest] Healthcare Provider Network Management Market Size Will Attain USD 12.48 Billion by 2034 Growing at 11.20% CAGR - Exclusive Report by ZMR | Global Healthcare Provider Network Management Market Size, Share, Trends Analysis Report https://ml.globenewswire.com/media/1f4cf0ab-7d76-4136-a6dc-a5545f80f538/small/zion-market-research-jpg.jpg https://iowahealthcarereporter.com/article/913628710-tomi-environmental-solutions-mobilizes-steramist-ihp-technology-in-response-to-emerging-global-pathogen-threats Iowa Healthcare Reporter en PressRelease 2026-05-19T13:20:00+00:00 TOMI™ Environmental Solutions Mobilizes SteraMist iHP Technology in Response to Emerging Global Pathogen Threats https://ml.globenewswire.com/media/f8c7c513-0121-4507-84b7-3680626d9cf3/small/tomi-jpg.jpg https://iowahealthcarereporter.com/article/913627595-merit-medical-shareholders-elect-scott-r-ward-to-board-of-directors Iowa Healthcare Reporter en PressRelease 2026-05-19T13:15:00+00:00 Merit Medical Shareholders Elect Scott R. Ward to Board of Directors https://ml.globenewswire.com/media/19958d8f-47a4-44f3-a780-247335a68768/small/merit-medical-systems-inc-logo.jpg https://iowahealthcarereporter.com/article/913627737-edesa-biotech-to-present-new-data-on-paridiprubart-in-acute-kidney-injury-at-european-nephrology-conference Iowa Healthcare Reporter en PressRelease 2026-05-19T13:15:00+00:00 Edesa Biotech to Present New Data on Paridiprubart in Acute Kidney Injury at European Nephrology Conference https://ml.globenewswire.com/media/36e957b9-bba2-48b4-a2ec-a471d945dcc4/small/logo-edesa-300dpi-r-jpg.jpg https://iowahealthcarereporter.com/article/913628233-after-five-decades-as-a-nurse-nightingale-college-educator-reflects-on-what-nursing-means-during-national-nurses-month Iowa Healthcare Reporter en PressRelease 2026-05-19T13:07:00+00:00 After Five Decades as a Nurse, Nightingale College Educator Reflects on What Nursing Means During National Nurses Month   https://ml.globenewswire.com/media/ZDQ1YTAzZWItMzBiOS00MjliLTg1NTMtYjZhZDg2YTkwYjJmLTEzMTIzMzQtMjAyNi0wNS0xOS1lbg==/tiny/Nightingale-College.png https://iowahealthcarereporter.com/article/913628548-commure-raises-70m-at-7b-valuation-to-transform-healthcare-operations-using-ai Iowa Healthcare Reporter en PressRelease 2026-05-19T13:04:36+00:00 Commure Raises $70M at $7B Valuation to Transform Healthcare Operations Using AI https://ml.globenewswire.com/media/1136e76f-ef70-46bf-997e-5f9b1b8b2ff6/small/commure-logo-full-horizontal-black-3-png.png https://iowahealthcarereporter.com/article/913627189-curia-completes-upgrade-of-api-aseptic-suites-in-valladolid-spain Iowa Healthcare Reporter en PressRelease 2026-05-19T13:00:00+00:00 Curia Completes Upgrade of API Aseptic Suites in Valladolid, Spain https://ml.globenewswire.com/media/40358b64-b515-41ec-8696-b7eb66c228e7/small/curia-logo-color-cmyk-updated-jpg.jpg https://iowahealthcarereporter.com/article/913627190-curia-schlie-t-die-modernisierung-der-api-aseptik-anlagen-in-valladolid-spanien-ab Iowa Healthcare Reporter en PressRelease 2026-05-19T13:00:00+00:00 Curia schließt die Modernisierung der API-Aseptik-Anlagen in Valladolid, Spanien, ab https://ml.globenewswire.com/media/40358b64-b515-41ec-8696-b7eb66c228e7/small/curia-logo-color-cmyk-updated-jpg.jpg https://iowahealthcarereporter.com/article/913627194-curia-completa-la-modernizaci-n-de-sus-salas-as-pticas-de-api-en-valladolid-espa-a Iowa Healthcare Reporter en PressRelease 2026-05-19T13:00:00+00:00 Curia completa la modernización de sus salas asépticas de API en Valladolid, España https://ml.globenewswire.com/media/40358b64-b515-41ec-8696-b7eb66c228e7/small/curia-logo-color-cmyk-updated-jpg.jpg https://iowahealthcarereporter.com/article/913627196-curia-ach-ve-la-modernisation-de-ses-unit-s-aseptiques-de-fabrication-d-api-valladolid-en-espagne Iowa Healthcare Reporter en PressRelease 2026-05-19T13:00:00+00:00 Curia achève la modernisation de ses unités aseptiques de fabrication d’API à Valladolid, en Espagne https://ml.globenewswire.com/media/40358b64-b515-41ec-8696-b7eb66c228e7/small/curia-logo-color-cmyk-updated-jpg.jpg https://iowahealthcarereporter.com/article/913627199-api Iowa Healthcare Reporter en PressRelease 2026-05-19T13:00:00+00:00 קוריה משלימה שדרוג של חדרי API אספטיים בוואלאדוליד, ספרד https://ml.globenewswire.com/media/40358b64-b515-41ec-8696-b7eb66c228e7/small/curia-logo-color-cmyk-updated-jpg.jpg https://iowahealthcarereporter.com/article/913627201-curia-menyelesaikan-peningkatan-pada-ruang-aseptik-api-di-valladolid-spanyol Iowa Healthcare Reporter en PressRelease 2026-05-19T13:00:00+00:00 Curia Menyelesaikan Peningkatan pada Ruang Aseptik API di Valladolid, Spanyol https://ml.globenewswire.com/media/40358b64-b515-41ec-8696-b7eb66c228e7/small/curia-logo-color-cmyk-updated-jpg.jpg https://iowahealthcarereporter.com/article/913627203-api Iowa Healthcare Reporter en PressRelease 2026-05-19T13:00:00+00:00 キュリア、スペインのバリャドリッドにあるAPI無菌製造施設のアップグレードを完了 https://ml.globenewswire.com/media/40358b64-b515-41ec-8696-b7eb66c228e7/small/curia-logo-color-cmyk-updated-jpg.jpg https://iowahealthcarereporter.com/article/913627207-curia-global-api Iowa Healthcare Reporter en PressRelease 2026-05-19T13:00:00+00:00 Curia Global, 스페인 바야돌리드 API 무균 생산 시설 업그레이드 완료 https://ml.globenewswire.com/media/40358b64-b515-41ec-8696-b7eb66c228e7/small/curia-logo-color-cmyk-updated-jpg.jpg https://iowahealthcarereporter.com/article/913627219-curia-menyelesaikan-penaiktarafan-suite-aseptik-api-di-valladolid-sepanyol Iowa Healthcare Reporter en PressRelease 2026-05-19T13:00:00+00:00 Curia Menyelesaikan Penaiktarafan Suite Aseptik API di Valladolid, Sepanyol https://ml.globenewswire.com/media/40358b64-b515-41ec-8696-b7eb66c228e7/small/curia-logo-color-cmyk-updated-jpg.jpg https://iowahealthcarereporter.com/article/913627268-curia-finaliza-upgrade-de-su-tes-ass-pticas-api-em-valladolid-espanha Iowa Healthcare Reporter en PressRelease 2026-05-19T13:00:00+00:00 Curia Finaliza Upgrade de Suítes Assépticas API em Valladolid, Espanha https://ml.globenewswire.com/media/40358b64-b515-41ec-8696-b7eb66c228e7/small/curia-logo-color-cmyk-updated-jpg.jpg https://iowahealthcarereporter.com/article/913627306-curia-api-valladolid Iowa Healthcare Reporter en PressRelease 2026-05-19T13:00:00+00:00 Curia ดำเนินการปรับปรุงห้องปฏิบัติการปลอดเชื้อสำหรับผลิต API ในเมือง Valladolid ประเทศสเปน… https://ml.globenewswire.com/media/40358b64-b515-41ec-8696-b7eb66c228e7/small/curia-logo-color-cmyk-updated-jpg.jpg https://iowahealthcarereporter.com/article/913627330-curia-api Iowa Healthcare Reporter en PressRelease 2026-05-19T13:00:00+00:00 Curia完成了西班牙巴利亚多利德API无菌生产线升级 https://ml.globenewswire.com/media/40358b64-b515-41ec-8696-b7eb66c228e7/small/curia-logo-color-cmyk-updated-jpg.jpg https://iowahealthcarereporter.com/article/913627380-curia Iowa Healthcare Reporter en PressRelease 2026-05-19T13:00:00+00:00 Curia 位於西班牙華拉度列的活性藥物成分無菌設施順利完成升級 https://ml.globenewswire.com/media/40358b64-b515-41ec-8696-b7eb66c228e7/small/curia-logo-color-cmyk-updated-jpg.jpg https://iowahealthcarereporter.com/article/913627433-livtech-appoints-samantha-mcalister-as-chief-customer-officer-to-drive-excellence-in-post-acute-care-technology Iowa Healthcare Reporter en PressRelease 2026-05-19T13:00:00+00:00 LivTech Appoints Samantha McAlister as Chief Customer Officer to Drive Excellence in Post-Acute Care Technology https://ml.globenewswire.com/media/NTFlZmJkOTctNDczZS00NDZiLTg4YmUtYzAyM2RhMzI0YTk5LTUwMDE1OTAzMC0yMDI2LTA1LTE5LWVu/tiny/LivTech.png https://iowahealthcarereporter.com/article/913627526-joshua-fritzler-named-president-of-olympia-and-wesley-pharmaceuticals Iowa Healthcare Reporter en PressRelease 2026-05-19T13:00:00+00:00 Joshua Fritzler Named President of Olympia and Wesley Pharmaceuticals https://ml.globenewswire.com/media/1ae3f24d-146b-426a-b595-06f38cce7ebf/small/logo-2024-png.png https://iowahealthcarereporter.com/article/913627749-uc-health-expands-access-to-liver-transplantation-with-the-paragonix-liverguard-system Iowa Healthcare Reporter en PressRelease 2026-05-19T13:00:00+00:00 UC Health Expands Access to Liver Transplantation with the Paragonix LIVERguard® System https://ml.globenewswire.com/media/5b56fec1-dc1d-480e-8a0b-aa723d7e7cf9/small/paragonix-getinge-bluecenter-png.png https://iowahealthcarereporter.com/article/913627754-nexgel-reports-positive-data-from-randomized-single-center-irb-study-to-evaluate-the-effectiveness-and-safety-of-a-hydrogel-laser-treatment-patch-in Iowa Healthcare Reporter en PressRelease 2026-05-19T13:00:00+00:00 NEXGEL Reports Positive Data from Randomized Single-Center IRB Study to Evaluate the Effectiveness and Safety of a Hydrogel Laser Treatment Patch in Laser Hair Removal with a 95.6% Reduction in Plume Concentration https://ml.globenewswire.com/media/0e76fff8-7aee-4b60-ba26-62dda9975939/small/logo-png.png https://iowahealthcarereporter.com/article/913627854-resmed-and-ura-partner-to-expand-access-to-sleep-health-education-and-care Iowa Healthcare Reporter en PressRelease 2026-05-19T13:00:00+00:00 Resmed and ŌURA Partner to Expand Access to Sleep Health Education and Care https://ml.globenewswire.com/media/fb7a34f4-d074-4bcf-b827-7a6a60924c46/small/resmed-h-pos-clr-rgb-250121-png.png https://iowahealthcarereporter.com/article/913627885-safespace-global-corp-otcid-ssgc-to-present-at-the-sidoti-micro-cap-virtual-conference-on-may-21st Iowa Healthcare Reporter en PressRelease 2026-05-19T13:00:00+00:00 SafeSpace Global Corp. (OTCID: SSGC) to Present at the Sidoti Micro-Cap Virtual Conference on May 21st https://ml.globenewswire.com/media/e95639ca-a47d-4c90-a44e-cf8a03b6a6d2/small/logo-jpg.jpg https://iowahealthcarereporter.com/article/913627933-envue-medical-to-showcase-envue-navigation-platform-at-aacn-nti-2026 Iowa Healthcare Reporter en PressRelease 2026-05-19T13:00:00+00:00 ENvue Medical to Showcase ENvue™ Navigation Platform at AACN NTI 2026 https://ml.globenewswire.com/media/e0a97028-a7c3-4dd6-a13f-a55e43617883/small/logo-small-722-jpg.jpg https://iowahealthcarereporter.com/article/913628211-dacadoo-and-bradesco-vida-e-previd-ncia-partner-to-bring-digital-health-engagement-to-millions-in-brazil Iowa Healthcare Reporter en PressRelease 2026-05-19T13:00:00+00:00 dacadoo and Bradesco Vida e Previdência Partner to Bring Digital Health Engagement to Millions in Brazil https://pressranger.s3.us-west-1.amazonaws.com/3271578/Bradesco.png https://iowahealthcarereporter.com/article/913628218-codex-labs-secures-two-u-s-patents-for-biacomplex-eczema-technology-with-two-peer-reviewed-clinical-trials-showing-up-to-99-symptom-reduction Iowa Healthcare Reporter en PressRelease 2026-05-19T13:00:00+00:00 Codex Labs Secures Two U.S. Patents for BiaComplex® Eczema Technology, With Two Peer-Reviewed Clinical Trials Showing Up to 99% Symptom Reduction — Without Steroids https://ml.globenewswire.com/media/OTdiYzc2YmUtNWUzNi00YTZhLTlkMzMtZjEyNjM1NDJlMDI1LTUwMDEzNDY5My0yMDI2LTA1LTE5LWVu/tiny/Codex-Labs-Corporation.png https://iowahealthcarereporter.com/article/913627177-propanc-biopharma-engages-european-cdmo-for-gmp-production-of-prp-for-phase-1b-fih-study-in-30-40-advanced-cancer-patients Iowa Healthcare Reporter en PressRelease 2026-05-19T12:45:00+00:00 Propanc Biopharma Engages European CDMO for GMP Production of PRP for Phase 1b, FIH Study in 30 – 40 Advanced Cancer Patients https://ml.globenewswire.com/media/0de2a486-4708-45bf-a406-f462ad395dec/small/propanc-logo-png.png https://iowahealthcarereporter.com/article/913628336-oragenics-to-present-at-sidoti-s-micro-cap-virtual-investor-conference-may-20-21 Iowa Healthcare Reporter en PressRelease 2026-05-19T12:45:00+00:00 Oragenics to Present at Sidoti’s Micro-Cap Virtual Investor Conference May 20-21 https://ml.globenewswire.com/media/8b2c9d06-f009-4a6e-a465-8a1fe9640993/small/logo-jpg.jpg https://iowahealthcarereporter.com/article/913609518-orchestra-biomed-to-participate-in-the-jefferies-global-healthcare-conference Iowa Healthcare Reporter en PressRelease 2026-05-19T12:30:00+00:00 Orchestra BioMed to Participate in the Jefferies Global Healthcare Conference https://ml.globenewswire.com/media/00697d05-bd34-4570-822b-f204caf21694/small/ogsk2sgeyptxenjnnf5a-png.png https://iowahealthcarereporter.com/article/913609690-nexalin-acquires-ai-integrated-digital-health-platform-behind-halo-clarity-and-nexalin-neurocare-ahead-of-planned-fda-pivotal-trial Iowa Healthcare Reporter en PressRelease 2026-05-19T12:30:00+00:00 Nexalin Acquires AI-Integrated Digital Health Platform Behind HALO™ Clarity and Nexalin NeuroCare™ Ahead of Planned FDA Pivotal Trial https://ml.globenewswire.com/media/7f481b55-16b6-4c8a-8356-30d54079a605/small/nexalin-jpg.jpg https://iowahealthcarereporter.com/article/913609809-autonomix-medical-inc-granted-u-s-patent-for-transvascular-monitoring-and-treatment-systems-with-real-time-procedural-validation Iowa Healthcare Reporter en PressRelease 2026-05-19T12:30:00+00:00 Autonomix Medical, Inc. Granted U.S. Patent for Transvascular Monitoring and Treatment Systems with Real-Time Procedural Validation https://ml.globenewswire.com/media/8b0ba1bc-43b1-4445-b895-712da30f7df8/small/logo-png.png https://iowahealthcarereporter.com/article/913610028-heartsciences-signs-commercial-agreement-with-north-shore-health-the-first-hospital-deployment-from-the-cibolo-health-network Iowa Healthcare Reporter en PressRelease 2026-05-19T12:30:00+00:00 HeartSciences Signs Commercial Agreement with North Shore Health, the First Hospital Deployment from the Cibolo Health Network https://ml.globenewswire.com/media/800a6aae-74f3-42bb-9199-5e169ed9b881/small/heartsciences-png.png https://iowahealthcarereporter.com/article/913610041-renovorx-to-present-at-the-alliance-global-partners-virtual-annual-healthcare-company-showcase-on-may-20th Iowa Healthcare Reporter en PressRelease 2026-05-19T12:30:00+00:00 RenovoRx to Present at the Alliance Global Partners Virtual Annual Healthcare Company Showcase on May 20th https://ml.globenewswire.com/media/e18bf823-ff44-4bbd-82b9-3a311d58dad8/small/final-logo-horizontal-png.png https://iowahealthcarereporter.com/article/913610401-prana-iv-therapy-highlights-emerging-research-on-magnesium-s-role-in-stress-and-neurological-function Iowa Healthcare Reporter en PressRelease 2026-05-19T12:30:00+00:00 Prana IV Therapy Highlights Emerging Research on Magnesium’s Role in Stress and Neurological Function https://ml.globenewswire.com/media/d9680bd6-b3b6-4639-ab47-fce11a5da464/small/final-logo-prana-color-squaretrans-png.png https://iowahealthcarereporter.com/article/913609211-risen-pharma-announces-initiation-of-phase-2-clinical-trial-of-rp902-for-mild-cognitive-impairment-due-to-alzheimer-s-disease Iowa Healthcare Reporter en PressRelease 2026-05-19T12:24:00+00:00 Risen Pharma Announces Initiation of Phase 2 Clinical Trial of RP902 for Mild Cognitive Impairment Due to Alzheimer’s Disease https://ml.globenewswire.com/media/ddbf001f-e225-4eed-a84f-300d305bb73a/small/risen-logo-night-blue-baby-blue-01-png.png https://iowahealthcarereporter.com/article/913610201-rp902-2 Iowa Healthcare Reporter en PressRelease 2026-05-19T12:24:00+00:00 リゼン・ファーマ、アルツハイマー病による軽度認知障害を対象としたRP902の、第2相治験の開始を発表 https://ml.globenewswire.com/media/ddbf001f-e225-4eed-a84f-300d305bb73a/small/risen-logo-night-blue-baby-blue-01-png.png https://iowahealthcarereporter.com/article/913610206-risen-pharma-rp902-2 Iowa Healthcare Reporter en PressRelease 2026-05-19T12:24:00+00:00 Risen Pharma, 알츠하이머병 관련 경도인지장애 치료제 RP902 임상 2상 개시 발표 https://ml.globenewswire.com/media/ddbf001f-e225-4eed-a84f-300d305bb73a/small/risen-logo-night-blue-baby-blue-01-png.png https://iowahealthcarereporter.com/article/913610219-amplexd-therapeutics-initiates-phase-2-clinical-trial-of-investigational-egcg-based-hpv-therapy Iowa Healthcare Reporter en PressRelease 2026-05-19T12:15:00+00:00 Amplexd Therapeutics Initiates Phase 2 Clinical Trial of Investigational EGCg-Based HPV Therapy https://ml.globenewswire.com/media/d274b355-3d09-4684-9ba1-e523a0d84cb3/small/banner-logo-1200-x-630-px-png.png https://iowahealthcarereporter.com/article/913609439-nkgen-biotech-expands-clinical-trial-site-network-for-alzheimer-s-disease-program-across-u-s-to-improve-patient-access-and-support-enrollment Iowa Healthcare Reporter en PressRelease 2026-05-19T12:05:00+00:00 NKGen Biotech Expands Clinical Trial Site Network for Alzheimer’s Disease Program Across U.S. to Improve Patient Access and Support Enrollment https://ml.globenewswire.com/media/756e1bcd-a22f-4971-bf36-2be2aa012814/small/nkgen-biotech-rgb-jpg.jpg https://iowahealthcarereporter.com/article/913609651-aim-immunotech-announces-significant-increase-in-stockholder-equity-and-extension-of-promissory-note-maturity-date-to-june-2027-enhancing-financial Iowa Healthcare Reporter en PressRelease 2026-05-19T12:02:00+00:00 AIM ImmunoTech Announces Significant Increase in Stockholder Equity and Extension of Promissory Note Maturity Date to June 2027, Enhancing Financial Flexibility and Supporting Strategic Clinical Priorities https://ml.globenewswire.com/media/8e85b83b-047f-4f99-9c51-1aa232ffe9bb/small/aimlogo-jpg.jpg https://iowahealthcarereporter.com/article/913609372-ardelyx-to-participate-at-the-jefferies-global-healthcare-conference-2026 Iowa Healthcare Reporter en PressRelease 2026-05-19T12:01:00+00:00 Ardelyx to Participate at the Jefferies Global Healthcare Conference 2026 https://ml.globenewswire.com/media/cee4ae6d-7a85-44bf-9c02-87e7fa934ec2/small/ardelyx-logo-rgb-jpg.jpg https://iowahealthcarereporter.com/article/913608564-matisse-pharmaceuticals-receives-fda-ind-clearance-for-isupartob-sodium Iowa Healthcare Reporter en PressRelease 2026-05-19T12:00:00+00:00 Matisse Pharmaceuticals receives FDA IND clearance for isupartob sodium https://ml-eu.globenewswire.com/media/463f1f88-9a63-4f6b-bcf0-da0f4352b838/medium/matisse-production-image.jpg https://iowahealthcarereporter.com/article/913608895-itm-to-announce-dosimetry-data-from-the-phase-3-compete-trial-at-snmmi-2026-and-host-satellite-symposium Iowa Healthcare Reporter en PressRelease 2026-05-19T12:00:00+00:00 ITM to Announce Dosimetry Data from the Phase 3 COMPETE Trial at SNMMI 2026 and Host Satellite Symposium https://ml-eu.globenewswire.com/media/3411c2bd-01a5-4d06-ad90-4a6e168bad61/small/itm-logo-claim-rgb-high-res-png.png https://iowahealthcarereporter.com/article/913609201-bone-biologics-achieves-29-month-validated-shelf-life-for-rhnell-1 Iowa Healthcare Reporter en PressRelease 2026-05-19T12:00:00+00:00 Bone Biologics Achieves 29-Month Validated Shelf Life for rhNELL-1 https://ml.globenewswire.com/media/71331977-9b21-4d4d-a57a-365bcc236328/small/bonebiologics-jpg.jpg https://iowahealthcarereporter.com/article/913609352-seven-peer-reviewed-studies-expand-research-into-vielight-s-light-based-neurotechnology Iowa Healthcare Reporter en PressRelease 2026-05-19T12:00:00+00:00 Seven Peer-Reviewed Studies Expand Research Into Vielight’s Light-Based Neurotechnology https://ml.globenewswire.com/media/NThiOTczYmEtMWE0Zi00ZjBiLThhZWQtZDEzNzAyNDVmZDY4LTUwMDE1MTI5Mi0yMDI2LTA1LTE5LWVu/tiny/Vielight-Inc-.png https://iowahealthcarereporter.com/article/913609378-black-diamond-therapeutics-to-host-webcast-for-investors-highlighting-updated-results-from-phase-2-trial-of-silevertinib-in-1l-egfrm-nsclc Iowa Healthcare Reporter en PressRelease 2026-05-19T12:00:00+00:00 Black Diamond Therapeutics to Host Webcast for Investors Highlighting Updated Results from Phase 2 Trial of Silevertinib in 1L EGFRm NSCLC https://ml.globenewswire.com/media/b8da4d92-789b-4f0a-a1e2-2739af370155/small/bdtxlogo-pantone3135c-png-png.png https://iowahealthcarereporter.com/article/913609505-biocardia-to-participate-in-a-fireside-chat-at-the-alliance-global-partners-a-g-p-healthcare-company-showcase Iowa Healthcare Reporter en PressRelease 2026-05-19T12:00:00+00:00 BioCardia to Participate in a Fireside Chat at the Alliance Global Partners (A.G.P) Healthcare Company Showcase https://ml.globenewswire.com/media/4641bb53-4913-4654-a337-79383a5c7ab9/small/biocardia-final-logo-2016-jpeg-jpg.jpg https://iowahealthcarereporter.com/article/913609538-science-37-and-tufts-csdd-publish-landmark-study-on-direct-to-patient-clinical-trial-site-performance-outperforming-industry-benchmarks Iowa Healthcare Reporter en PressRelease 2026-05-19T12:00:00+00:00 Science 37 and Tufts CSDD Publish Landmark Study on Direct-to-Patient Clinical Trial Site Performance, Outperforming Industry Benchmarks https://ml.globenewswire.com/media/2379cb21-af9e-4ac6-860e-e13903c9a83a/small/science-37-logo-jpg.jpg https://iowahealthcarereporter.com/article/913609636-artiva-biotherapeutics-appoints-veteran-biotech-executive-and-drug-developer-diego-miralles-m-d-as-president-and-head-of-research-and-development Iowa Healthcare Reporter en PressRelease 2026-05-19T12:00:00+00:00 Artiva Biotherapeutics Appoints Veteran Biotech Executive and Drug Developer Diego Miralles, M.D., as President and Head of Research and Development https://ml.globenewswire.com/media/0392544b-ecff-4590-9eed-59c934e1ba4d/small/artiva-biotherapeutics-logo-jpg.jpg https://iowahealthcarereporter.com/article/913609659-brainhq-awarded-the-gold-earns-trusted-digital-badge-from-apa-labs-a-unit-of-american-psychological-association-services-inc Iowa Healthcare Reporter en PressRelease 2026-05-19T12:00:00+00:00 BrainHQ Awarded the Gold: Earns Trusted Digital Badge from APA Labs, a unit of American Psychological Association Services, Inc. https://ml.globenewswire.com/media/786e4982-1a22-4d50-b0ac-6d9cb502b3f6/small/logo-brainhq-hi-res-hori-png.png https://iowahealthcarereporter.com/article/913610027-lifeward-appoints-dr-keith-d-rose-as-chief-medical-officer-to-support-expansion-of-neurorehabilitation-portfolio-and-advance-biomed-platform Iowa Healthcare Reporter en PressRelease 2026-05-19T12:00:00+00:00 Lifeward Appoints Dr. Keith D. Rose as Chief Medical Officer to Support Expansion of Neurorehabilitation Portfolio and Advance Biomed Platform https://ml.globenewswire.com/media/9343d7ac-5bc7-4a60-a2c9-a41bf7b5e007/small/lifeward-full-logo-rgb-for-web-01-jpg.jpg https://iowahealthcarereporter.com/article/913610148-onconetix-inc-announces-1-for-10-reverse-stock-split Iowa Healthcare Reporter en PressRelease 2026-05-19T12:00:00+00:00 Onconetix, Inc. Announces 1-for-10 Reverse Stock Split https://ml.globenewswire.com/media/4824d51d-2ecb-4f49-8b75-fe9b920e7b1c/small/onconetix-logo-jpg.jpg https://iowahealthcarereporter.com/article/913610157-true-see-reports-new-peer-reviewed-publication-that-highlights-the-critical-role-of-accuracy-and-quality-standards-in-medical-photography Iowa Healthcare Reporter en PressRelease 2026-05-19T12:00:00+00:00 TRUE-See Reports New Peer-Reviewed Publication that Highlights the Critical Role of Accuracy and Quality Standards in Medical Photography https://ml.globenewswire.com/media/ddbe53f8-af0b-4640-b075-3cb1c7cba9df/small/2024-ts-png.png https://iowahealthcarereporter.com/article/913610253-suo-ctc-and-cg-oncology-announce-award-recipients-of-the-second-annual-non-muscle-invasive-bladder-cancer-nmibc-research-fellowship-award Iowa Healthcare Reporter en PressRelease 2026-05-19T12:00:00+00:00 SUO-CTC and CG Oncology Announce Award Recipients of the Second Annual Non-Muscle Invasive Bladder Cancer (NMIBC) Research Fellowship Award https://ml.globenewswire.com/media/9e1cbdea-928e-4ea4-b4cd-33cdc36c6b2f/small/cgoncology-cover-jpg.jpg https://iowahealthcarereporter.com/article/913610278-brain-cancer-canada-invests-75-000-in-groundbreaking-glioblastoma-research-at-university-of-alberta-targeting-how-tumours-communicate Iowa Healthcare Reporter en PressRelease 2026-05-19T12:00:00+00:00 Brain Cancer Canada Invests $75,000 in Groundbreaking Glioblastoma Research at University of Alberta, Targeting How Tumours “Communicate” https://ml.globenewswire.com/media/78a73b7f-a470-42a5-9976-aa425939a68b/small/bcc-logo-2024-png.png https://iowahealthcarereporter.com/article/913609668-plus-therapeutics-partners-with-ephemeral-technologies-to-deploy-ai-execution-platform-for-cns-oncology Iowa Healthcare Reporter en PressRelease 2026-05-19T11:30:00+00:00 Plus Therapeutics Partners with Ephemeral Technologies to Deploy AI Execution Platform for CNS Oncology https://ml.globenewswire.com/media/92d7aa70-e37d-4870-bccf-d83b68ba5612/small/plus-logo-png.png https://iowahealthcarereporter.com/article/913609673-vertero-advances-into-phase-1b-study-with-vt-5006-for-the-treatment-of-parkinson-s-disease Iowa Healthcare Reporter en PressRelease 2026-05-19T11:30:00+00:00 Vertero Advances into Phase 1b Study with VT-5006 for the Treatment of Parkinson’s Disease https://ml.globenewswire.com/media/1f35b823-7c3a-4b49-b782-65409c4e2599/small/vertero-400x400-tm-png.png https://iowahealthcarereporter.com/article/913609723-alterity-therapeutics-data-presentations-support-advancement-of-ath434-into-phase-3-in-multiple-system-atrophy Iowa Healthcare Reporter en PressRelease 2026-05-19T11:25:00+00:00 Alterity Therapeutics Data Presentations Support Advancement of ATH434 into Phase 3 in Multiple System Atrophy https://ml.globenewswire.com/media/0771a9a2-2ac1-4a63-9767-a2b1df74af27/small/alterity-png.png https://iowahealthcarereporter.com/article/913609139-crb-horizons-report-reveals-food-and-beverage-manufacturers-confront-aging-facilities-labor-shortages-and-regulatory-pressure-amid-rising-safety Iowa Healthcare Reporter en PressRelease 2026-05-19T11:05:00+00:00 CRB Horizons Report Reveals Food and Beverage Manufacturers Confront Aging Facilities, Labor Shortages, and Regulatory Pressure Amid Rising Safety Risks https://ml.globenewswire.com/media/NTBjMzg2YjAtNWZjNy00N2U4LWFkMGMtYWQxYjMzMGQ5NGE2LTUwMDEzMTU2Ni0yMDI2LTA1LTE5LWVu/tiny/CRB-Group-Inc-.png https://iowahealthcarereporter.com/article/913610002-zenas-biopharma-announces-upcoming-presentation-of-results-from-phase-3-indigo-registrational-trial-of-obexelimab-in-immunoglobulin-g4-related-disease Iowa Healthcare Reporter en PressRelease 2026-05-19T11:05:00+00:00 Zenas BioPharma Announces Upcoming Presentation of Results from Phase 3 INDIGO Registrational Trial of Obexelimab in Immunoglobulin G4-Related Disease (IgG4-RD) at EULAR 2026 Congress https://ml.globenewswire.com/media/11a7c081-eaf9-4e1d-b413-227c20d8d41a/small/zenas-logo-jpg.jpg https://iowahealthcarereporter.com/article/913609543-vanqua-bio-to-present-positive-biomarker-data-from-ongoing-phase-1b-study-at-upcoming-medical-conferences Iowa Healthcare Reporter en PressRelease 2026-05-19T11:02:00+00:00 Vanqua Bio to Present Positive Biomarker Data from Ongoing Phase 1b Study at Upcoming Medical Conferences https://ml.globenewswire.com/media/53a0d466-4abe-49c6-87a8-7b04b1a0c159/small/vanquabio-stacked-jpg.jpg https://iowahealthcarereporter.com/article/913608574-herantis-pharma-partners-with-indivi-to-enable-detection-of-early-treatment-effects-in-upcoming-her-096-phase-2-trial-in-parkinson-s-disease Iowa Healthcare Reporter en PressRelease 2026-05-19T11:00:00+00:00 Herantis Pharma partners with Indivi to enable detection of early treatment effects in upcoming HER-096 Phase 2 trial in Parkinson’s disease https://ml-eu.globenewswire.com/media/f36fe595-29a9-4dc0-b4a9-c250fe4e3935/small/herantis-png.png https://iowahealthcarereporter.com/article/913609356-cullinan-therapeutics-receives-fda-orphan-drug-designation-for-cln-049-a-novel-flt3xcd3-t-cell-engager-in-relapsed-refractory-acute-myeloid-leukemia Iowa Healthcare Reporter en PressRelease 2026-05-19T11:00:00+00:00 Cullinan Therapeutics Receives FDA Orphan Drug Designation for CLN-049, a Novel FLT3xCD3 T Cell Engager, in Relapsed/Refractory Acute Myeloid Leukemia https://ml.globenewswire.com/media/3f4113d3-b651-4c00-bd96-c1ff9384b1de/small/cullinan-logo-rgb-clr-png.png https://iowahealthcarereporter.com/article/913609481-eyepoint-announces-participation-at-upcoming-investor-conferences Iowa Healthcare Reporter en PressRelease 2026-05-19T11:00:00+00:00 EyePoint Announces Participation at Upcoming Investor Conferences https://ml.globenewswire.com/media/3934240c-3155-4c7d-a525-885791fdab8b/small/eypoint-new-reg-vertical-3c-rgb1-jpg.jpg https://iowahealthcarereporter.com/article/913610014-xortx-announces-closing-of-us-5-million-public-offering Iowa Healthcare Reporter en PressRelease 2026-05-19T11:00:00+00:00 XORTX Announces Closing of US$5 Million Public Offering https://ml.globenewswire.com/media/9898c4f8-b373-438a-abfa-709c4372a061/small/xortx-logo-jpg.jpg https://iowahealthcarereporter.com/article/913610020-lexeo-therapeutics-to-participate-in-the-2026-rbc-capital-markets-global-healthcare-conference Iowa Healthcare Reporter en PressRelease 2026-05-19T11:00:00+00:00 Lexeo Therapeutics to Participate in the 2026 RBC Capital Markets Global Healthcare Conference https://ml.globenewswire.com/media/85c275df-e665-426f-a3bc-4a839a0b34d3/small/lexeo-logo-png.png https://iowahealthcarereporter.com/article/913610026-korro-selects-krro-111-as-development-candidate-for-the-potential-treatment-of-alpha-1-antitrypsin-deficiency-aatd Iowa Healthcare Reporter en PressRelease 2026-05-19T11:00:00+00:00 Korro Selects KRRO-111 as Development Candidate for the Potential Treatment of Alpha-1 Antitrypsin Deficiency (AATD) https://ml.globenewswire.com/media/d49fc3c4-5cf6-4b89-8434-2eadfff25c26/small/korro-logo-rgb-jpg.jpg https://iowahealthcarereporter.com/article/913610142-medicenna-announces-the-finalization-of-the-terms-of-its-public-offering-of-securities Iowa Healthcare Reporter en PressRelease 2026-05-19T11:00:00+00:00 Medicenna Announces the Finalization of the Terms of its Public Offering of Securities https://ml.globenewswire.com/media/7e312e67-9924-4773-b548-47ed05d54904/small/new-logo-small-png.png https://iowahealthcarereporter.com/article/913610211-okyo-expands-scientific-advisory-board-with-the-appointment-of-international-expert-marta-sacchetti-md-phd Iowa Healthcare Reporter en PressRelease 2026-05-19T11:00:00+00:00 OKYO Expands Scientific Advisory Board with the Appointment of International Expert Marta Sacchetti, MD, PhD https://ml.globenewswire.com/media/23e4046d-dcf9-4dd1-945e-461e98a27d15/small/full-logo-okyo-jpg.jpg https://iowahealthcarereporter.com/article/913610242-tiziana-announces-new-positive-clinical-data-for-intranasal-foralumab-in-non-active-secondary-progressive-multiple-sclerosis Iowa Healthcare Reporter en PressRelease 2026-05-19T11:00:00+00:00 Tiziana Announces New Positive Clinical Data for Intranasal Foralumab in Non-Active Secondary Progressive Multiple Sclerosis https://ml.globenewswire.com/media/4621ceef-fd52-40d4-a109-6de0710304f4/medium/figure-1.png https://iowahealthcarereporter.com/article/913610257-biometrics-as-a-service-in-medical-devices-to-reach-2-7-billion-by-2030-driven-by-remote-patient-monitoring-demand Iowa Healthcare Reporter en PressRelease 2026-05-19T10:59:48+00:00 Biometrics as a Service in Medical Devices to Reach $2.7 Billion by 2030, Driven by Remote Patient Monitoring Demand https://ml.globenewswire.com/media/d0c282b6-d496-45a8-a941-33fa5c3e824c/small/bcc-logo-1200-630-png.png https://iowahealthcarereporter.com/article/913609830-europcr-2026-dynamx-bioadaptor-von-elixir-medical-zeigt-in-der-langzeit-nachbeobachtung-signifikant-niedrigere-ereignisraten-als-ein Iowa Healthcare Reporter en PressRelease 2026-05-19T10:50:00+00:00 EuroPCR 2026: DynamX® Bioadaptor von Elixir Medical zeigt in der Langzeit-Nachbeobachtung signifikant niedrigere Ereignisraten als ein medikamentenfreisetzender Stent https://ml.globenewswire.com/media/9d46c455-99b0-47b2-b593-beb9969709c2/small/ https://iowahealthcarereporter.com/article/913609856-europcr-2026-elixir-medical-s-dynamx-bioadaptor-demonstrates-significantly-lower-event-rates-than-drug-eluting-stent Iowa Healthcare Reporter en PressRelease 2026-05-19T10:50:00+00:00 EuroPCR 2026: Elixir Medical’s DynamX® Bioadaptor Demonstrates Significantly Lower Event Rates Than Drug-Eluting Stent https://ml.globenewswire.com/media/9d46c455-99b0-47b2-b593-beb9969709c2/small/elixir-logo-white-png.png https://iowahealthcarereporter.com/article/913609870-el-bioadaptador-dynamx-de-elixir-medical-demuestra-tasas-de-acontecimientos-significativamente-inferiores-a-las-de-los-stents-liberadores-de-f-rmacos Iowa Healthcare Reporter en PressRelease 2026-05-19T10:50:00+00:00 El bioadaptador DynamX® de Elixir Medical demuestra tasas de acontecimientos significativamente inferiores a las de los stents liberadores de fármacos https://ml.globenewswire.com/media/9d46c455-99b0-47b2-b593-beb9969709c2/small/ https://iowahealthcarereporter.com/article/913609873-le-bioadaptateur-dynamx-d-elixir-medical-d-montre-une-r-duction-significative-des-taux-d-v-nements-coronariens-par-rapport-un-stent-lution Iowa Healthcare Reporter en PressRelease 2026-05-19T10:50:00+00:00 Le Bioadaptateur DynamX® d’Elixir Medical démontre une réduction significative des taux d’événements coronariens par rapport à un stent à élution médicamenteuse https://ml.globenewswire.com/media/9d46c455-99b0-47b2-b593-beb9969709c2/small/ https://iowahealthcarereporter.com/article/913609888-europcr-2026-dynamx-bioadaptor-di-elixir-medical-mostra-tassi-di-eventi-significativamente-inferiori-rispetto-allo-stent-a-rilascio-di-farmaco Iowa Healthcare Reporter en PressRelease 2026-05-19T10:50:00+00:00 EuroPCR 2026: DynamX® Bioadaptor di Elixir Medical mostra tassi di eventi significativamente inferiori rispetto allo stent a rilascio di farmaco https://ml.globenewswire.com/media/9d46c455-99b0-47b2-b593-beb9969709c2/small/ https://iowahealthcarereporter.com/article/913609898-europcr-2026-bioadaptator-dynamx-firmy-elixir-medical-wykazuje-istotne-obni-enie-wyst-powania-zdarze-niepo-danych Iowa Healthcare Reporter en PressRelease 2026-05-19T10:50:00+00:00 EuroPCR 2026: Bioadaptator DynamX® firmy Elixir Medical wykazuje istotne obniżenie występowania zdarzeń niepożądanych https://ml.globenewswire.com/media/9d46c455-99b0-47b2-b593-beb9969709c2/small/ https://iowahealthcarereporter.com/article/913609206-avance-clinical-to-showcase-oncology-leadership-at-asco-annual-meeting-2026 Iowa Healthcare Reporter en PressRelease 2026-05-19T10:30:00+00:00 Avance Clinical to Showcase Oncology Leadership at ASCO Annual Meeting 2026 https://ml.globenewswire.com/media/d962b5ae-4411-409e-b901-c81c838d1ad1/small/avance-solid-logo-high-res-jpg.jpg https://iowahealthcarereporter.com/article/913590172-natural-alternatives-international-inc-announces-2026-q3-and-ytd-results Iowa Healthcare Reporter en PressRelease 2026-05-19T10:15:00+00:00 Natural Alternatives International, Inc. Announces 2026 Q3 and YTD Results https://ml.globenewswire.com/media/4b40dd5b-0137-41f8-83de-422e4b4f3196/small/nai-full-logo-green2-0-png.png https://iowahealthcarereporter.com/article/913590181-relay-therapeutics-announces-initial-clinical-data-demonstrating-that-zovegalisib-has-potential-for-differentiated-safety-and-efficacy-in-patients Iowa Healthcare Reporter en PressRelease 2026-05-19T10:00:00+00:00 Relay Therapeutics Announces Initial Clinical Data Demonstrating That Zovegalisib Has Potential for Differentiated Safety and Efficacy in Patients with PIK3CA-Driven Vascular Anomalies https://ml.globenewswire.com/media/079b6db5-ce81-4a81-9cde-d97f86c569ae/small/logo-banner-small-png.png https://iowahealthcarereporter.com/article/913590220-clearmind-medicine-announces-1-for-10-reverse-share-split Iowa Healthcare Reporter en PressRelease 2026-05-19T10:00:00+00:00 Clearmind Medicine Announces 1-for-10 Reverse Share Split https://ml.globenewswire.com/media/bd17cbf4-8124-4f86-8a4c-1fafbb6785af/small/logo-jpg.jpg https://iowahealthcarereporter.com/article/913590077-genosafe-advances-clia-pathway-for-transatlantic-atmp-development Iowa Healthcare Reporter en PressRelease 2026-05-19T09:00:00+00:00 GenoSafe advances CLIA pathway for transatlantic ATMP development https://ml-eu.globenewswire.com/media/72bb1656-3d66-4582-bec0-f3fe365d3415/small/teams-zoom-background-helio-v2-png.png https://iowahealthcarereporter.com/article/913590088-hephaistos-pharma-appoints-stephan-braun-as-chief-medical-officer-to-lead-clinical-development-strategy Iowa Healthcare Reporter en PressRelease 2026-05-19T09:00:00+00:00 HEPHAISTOS-Pharma appoints Stephan Braun as Chief Medical Officer to lead clinical development strategy https://ml-eu.globenewswire.com/media/2d199475-8ee7-40a8-b726-1f77bc1f8079/small/hephaistos-logo-medium-png.png https://iowahealthcarereporter.com/article/913590198-featol-introduces-ergonomic-wrist-support-for-modern-repetitive-strain-challenges Iowa Healthcare Reporter en PressRelease 2026-05-19T08:22:17+00:00 FEATOL Introduces Ergonomic Wrist Support for Modern Repetitive Strain Challenges https://ml.globenewswire.com/media/38bbd2c6-79de-4f62-b21a-26b9afe5b3c3/medium/tendonitis.png https://iowahealthcarereporter.com/article/913573915-mabylon-reports-positive-phase-ia-results-in-my006-peanut-allergy-trial-and-initiates-phase-ib-patient-part-of-the-study-advances-tree-pollen-allergy Iowa Healthcare Reporter en PressRelease 2026-05-19T08:00:00+00:00 Mabylon Reports Positive Phase Ia Results in MY006 Peanut Allergy Trial and Initiates Phase Ib Patient Part of the Study; Advances Tree Pollen Allergy Program MY010 toward Clinical Development https://ml-eu.globenewswire.com/media/YTczOTYzOTYtMzliYS00MmM1LTg2YjItY2MxMWE0NGE4ZjFhLTEwMzc0NTQtMjAyNi0wNS0xOS1lbg==/tiny/AKAMPION.png https://iowahealthcarereporter.com/article/913573960-adrenomed-highlights-need-for-personalized-therapies-in-septic-shock-amid-new-sepsis-guidelines-and-u-s-policy-initiative Iowa Healthcare Reporter en PressRelease 2026-05-19T08:00:00+00:00 AdrenoMed Highlights Need for Personalized Therapies in Septic Shock Amid New Sepsis Guidelines and U.S. Policy Initiative https://ml.globenewswire.com/media/10aa6d83-e8fc-47cb-871f-facbec82a967/small/adrenomed-logo-002-jpg.jpg https://iowahealthcarereporter.com/article/913573967-anaveon-strengthens-leadership-team-with-appointments-of-eric-zanelli-as-chief-scientific-officer-and-jill-jene-as-chief-business-officer Iowa Healthcare Reporter en PressRelease 2026-05-19T08:00:00+00:00 Anaveon Strengthens Leadership Team with Appointments of Eric Zanelli as Chief Scientific Officer and Jill Jene as Chief Business Officer https://ml.globenewswire.com/media/376f71da-1a19-4a9a-bb0a-5d12feb63780/small/logo-anaveon-jpg.jpg https://iowahealthcarereporter.com/article/913573920-mestag-therapeutics-announces-the-first-patient-dosed-with-mst-0312-in-the-phase-i-starlys-trial Iowa Healthcare Reporter en PressRelease 2026-05-19T07:30:00+00:00 Mestag Therapeutics Announces the First Patient Dosed with MST-0312 in the Phase I STARLYS Trial https://ml-eu.globenewswire.com/media/d47c1200-a3a8-42b0-b0b9-ffb74568b42c/small/mestag-tx-logo-png.png https://iowahealthcarereporter.com/article/913573994-unaudited-preliminary-results-for-the-year-ended-december-31-2025 Iowa Healthcare Reporter en PressRelease 2026-05-19T06:14:37+00:00 Unaudited Preliminary Results for the Year Ended December 31, 2025 https://ml.globenewswire.com/media/63584766-21c6-42e8-944c-7103432b045b/small/avacta-logo-full-color-rgb-oct-2024-jpg.jpg https://iowahealthcarereporter.com/article/913562075-khondrion-announces-first-patient-dosed-in-phase-ii-study-targeting-debilitating-post-covid-fatigue Iowa Healthcare Reporter en PressRelease 2026-05-19T06:00:00+00:00 Khondrion Announces First Patient Dosed in Phase II Study Targeting Debilitating Post-COVID Fatigue https://ml-eu.globenewswire.com/media/MzNlYmI3ODQtY2JmMi00OWJmLWI3NmUtNGY1ODY5ODE0MDJhLTEzMjMxNjctMjAyNi0wNS0xOS1lbg==/tiny/Khondrion-B-V-.png https://iowahealthcarereporter.com/article/913562147-onward-medical-to-announce-first-quarter-2026-results-on-may-26-2026 Iowa Healthcare Reporter en PressRelease 2026-05-19T05:30:00+00:00 ONWARD Medical to Announce First Quarter 2026 Results on May 26, 2026 https://ml.globenewswire.com/media/a60261ec-0c66-4acb-8726-e567073990a2/small/onwardresized1-png.png https://iowahealthcarereporter.com/article/913562155-serb-pharmaceuticals-to-acquire-european-and-mena-rights-to-idefirix-imlifidase-from-hansa-biopharma-for-115-million Iowa Healthcare Reporter en PressRelease 2026-05-19T05:30:00+00:00 SERB Pharmaceuticals to acquire European and MENA rights to Idefirix® (imlifidase) from Hansa Biopharma for €115 million https://ml.globenewswire.com/media/7862df2f-dd67-489b-973a-030c1c164344/small/serb-rgb-trimmed-png.png https://iowahealthcarereporter.com/article/913551361-rapid-nutrition-advances-finalization-of-australian-flagship-initiative Iowa Healthcare Reporter en PressRelease 2026-05-19T03:00:00+00:00 Rapid Nutrition Advances Finalization of Australian Flagship Initiative https://ml-eu.globenewswire.com/media/f5152816-94d7-4584-a49f-05ae66a44bf0/small/rapid-jpg.jpg https://iowahealthcarereporter.com/article/913551430-fangzhou-ranked-among-2025-guangzhou-ai-innovation-most-promising-enterprises-for-ai-powered-chronic-disease-services Iowa Healthcare Reporter en PressRelease 2026-05-19T02:38:12+00:00 Fangzhou Ranked among 2025 Guangzhou AI Innovation “Most Promising Enterprises” for AI‑Powered Chronic Disease Services https://ml.globenewswire.com/media/c2774e85-7115-4320-ad5e-ff2704381fe3/medium/fangzhou-ranked-among-2025-guangzhou-ai-innovation-most-prom.jpg https://iowahealthcarereporter.com/article/913539821-rapid-micro-biosystems-announces-pricing-of-up-to-approximately-32-million-underwritten-offering Iowa Healthcare Reporter en PressRelease 2026-05-19T01:55:00+00:00 Rapid Micro Biosystems Announces Pricing of Up to Approximately $32 Million Underwritten Offering https://ml.globenewswire.com/media/12585575-0b2e-4369-bf15-500b17ccb859/small/rapid-micro-biosystems-logo.png https://iowahealthcarereporter.com/article/913523447-star-room-at-vista-del-monte-honored-for-best-practice-innovation-of-the-year Iowa Healthcare Reporter en PressRelease 2026-05-18T22:28:06+00:00 Star Room at Vista del Monte honored for Best Practice/Innovation of the Year https://ml.globenewswire.com/media/MDQxYWI4MjAtOTBhOC00YWRkLTk4MDctMWU1MmVkYWU3NjhkLTUwMDE1ODQ1Ni0yMDI2LTA1LTE4LWVu/tiny/Front-Porch-Communities-and-Se.png https://iowahealthcarereporter.com/article/913507096-pennant-group-to-participate-in-the-2026-rbc-global-healthcare-conference Iowa Healthcare Reporter en PressRelease 2026-05-18T22:03:54+00:00 Pennant Group to Participate in the 2026 RBC Global Healthcare Conference https://ml.globenewswire.com/media/d50f543c-fc54-437d-8007-600644587dfe/small/pennant-logo-png.png